<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Ketamine,Articles with unsourced statements since December 2008,Articles with unsourced statements since November 2007,Articles with unsourced statements since July 2007,Articles with unsourced statements since February 2007,Articles needing additional references from December 2008,Articles with unsourced statements since August 2007,Fact,Dissociative psychedelics,Glutamate receptor ligands,General anesthetics" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Ketamine&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Ketamine&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Ketamine - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Ketamine";
		var wgTitle = "Ketamine";
		var wgAction = "view";
		var wgArticleId = "16948";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281164294;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Ketamine skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Ketamine</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Ketamine-2D-skeletal.png" class="image" title="Ketamine-2D-skeletal.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/5a/Ketamine-2D-skeletal.png/150px-Ketamine-2D-skeletal.png" width="150" height="139" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:R-ketamine-3D-balls.png" class="image" title="R-ketamine-3D-balls.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/82/R-ketamine-3D-balls.png/150px-R-ketamine-3D-balls.png" width="150" height="169" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Ketamine</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px">2-(2-chlorophenyl)- 2-methylamino- cyclohexan- 1-one</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=6740-88-1&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=6740-88-1&amp;rn=1" rel="nofollow">6740-88-1</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_N01" title="ATC code N01">N01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N01AX03" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N01AX03" rel="nofollow">AX03</a></span> <a href="/wiki/ATC_code_N01" title="ATC code N01">N01</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N01AX14" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=N01AX14" rel="nofollow">AX14</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3821" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3821" rel="nofollow">3821</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00493" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD00493" rel="nofollow">APRD00493</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.chemspider.com/Chemical-Structure.3689" class="external text" title="http://www.chemspider.com/Chemical-Structure.3689" rel="nofollow">3689</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>13</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>16</sub><a href="/wiki/Chlorine" title="Chlorine"><span style="color: rgb(15,95,15); font-weight: bold;">Cl</span></a><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><a href="/wiki/Oxygen" title="Oxygen"><span style="color: rgb(116,35,35); font-weight: bold;">O</span></a><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">237.725 g/mol</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification">SMILES</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=C1%28%3DC%28C%3DCC%3DC1%29Cl%29C2%28CCCCC2%3DO%29N%28C%29%5BH%5D" class="external text" title="http://www.emolecules.com/cgi-bin/search?t=ex&amp;q=C1%28%3DC%28C%3DCC%3DC1%29Cl%29C2%28CCCCC2%3DO%29N%28C%29%5BH%5D" rel="nofollow">eMolecules</a></span> &amp; <span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=C1%28%3DC%28C%3DCC%3DC1%29Cl%29C2%28CCCCC2%3DO%29N%28C%29%5BH%5D" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/search/?smarts=C1%28%3DC%28C%3DCC%3DC1%29Cl%29C2%28CCCCC2%3DO%29N%28C%29%5BH%5D" rel="nofollow">PubChem</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">&#160;?</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">Hepatic, primarily by CYP3A4<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">2.5-3 hours.</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">renal (&gt;90%)</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>B</p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/Controlled_Drugs_and_Substances_Act#Schedule_I" title="Controlled Drugs and Substances Act">Schedule I</a><small>(<a href="/wiki/Canada" title="Canada">CA</a>)</small> <a href="/wiki/Misuse_of_Drugs_Act_1971#Class_C_drugs" title="Misuse of Drugs Act 1971">Class C</a><small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small> <a href="/wiki/Controlled_Substances_Act#Schedule_III_drugs" title="Controlled Substances Act">Schedule III</a><small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Intravenous_therapy" title="Intravenous therapy">IV</a>, <a href="/wiki/Intramuscular_injection" title="Intramuscular injection">IM</a>, <a href="/wiki/Insufflation_(medicine)" title="Insufflation (medicine)">Insufflated</a>, oral, <a href="/wiki/Topical" title="Topical">topical</a></td>
</tr>
</table>
<p><b>Ketamine</b> is a <a href="/wiki/Drug" title="Drug">drug</a> used in human and <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary medicine</a> developed by <a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a> (today a part of <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>) in 1962. Its <a href="/wiki/Hydrochloride_salt" title="Hydrochloride salt" class="mw-redirect">hydrochloride salt</a> is sold as <b>Ketanest</b>, <b>Ketaset</b>, and <b>Ketalar</b>. <a href="/wiki/Pharmacology" title="Pharmacology">Pharmacologically</a>, ketamine is classified as an <a href="/wiki/NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonist</a><sup id="cite_ref-harrison_1-0" class="reference"><a href="#cite_note-harrison-1" title=""><span>[</span>2<span>]</span></a></sup>. At high, fully anesthetic level doses, ketamine has also been found to bind to <a href="/wiki/Opioid" title="Opioid">opioid</a> <a href="/wiki/Mu_Opioid_receptor" title="Mu Opioid receptor">μ receptors</a> and <a href="/wiki/Sigma_receptor" title="Sigma receptor">sigma receptors</a>.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Like other drugs of this class such as <a href="/wiki/Tiletamine" title="Tiletamine">tiletamine</a> and <a href="/wiki/Phencyclidine" title="Phencyclidine">phencyclidine</a> (PCP), it induces a state referred to as "<a href="/wiki/Dissociative_drug" title="Dissociative drug">dissociative anesthesia</a>"<sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> and is used as a <a href="/wiki/Recreational_drug" title="Recreational drug" class="mw-redirect">recreational drug</a>.</p>
<p>Ketamine has a wide range of effects in humans, including <a href="/wiki/Analgesia" title="Analgesia" class="mw-redirect">analgesia</a>, <a href="/wiki/Anesthesia" title="Anesthesia">anesthesia</a>, <a href="/wiki/Hallucination" title="Hallucination">hallucinations</a>, elevated <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a>, and <a href="/wiki/Bronchodilator" title="Bronchodilator">bronchodilation</a>.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since November 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Ketamine is primarily used for the induction and maintenance of <a href="/wiki/General_anesthesia" title="General anesthesia" class="mw-redirect">general anesthesia</a>, usually in combination with some sedative drug. Other uses include <a href="/wiki/Sedative" title="Sedative">sedation</a> in <a href="/wiki/Intensive_care" title="Intensive care" class="mw-redirect">intensive care</a>, <a href="/wiki/Analgesia" title="Analgesia" class="mw-redirect">analgesia</a> (particularly in emergency medicine), and treatment of <a href="/wiki/Bronchospasm" title="Bronchospasm">bronchospasm</a>. It is also a popular anesthetic in <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary medicine</a>.</p>
<p>Ketamine is a <a href="/wiki/Chirality_(chemistry)" title="Chirality (chemistry)">chiral</a> compound. Most pharmaceutical preparations of ketamine are <a href="/wiki/Racemic" title="Racemic" class="mw-redirect">racemic</a>; however, some brands reportedly have (mostly undocumented) differences in enantiomeric proportions. The more active <a href="/wiki/Enantiomer" title="Enantiomer">enantiomer</a>, S-ketamine, is also available for medical use under the brand name <b>Ketanest S</b>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup> Ketamine is a <i>core</i> medicine in the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a>'s "<a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines" class="mw-redirect">Essential Drugs List</a>", which is a list of minimum medical needs for a basic health care system.<sup id="cite_ref-essentialWHO_4-0" class="reference"><a href="#cite_note-essentialWHO-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Medical_use"><span class="tocnumber">2</span> <span class="toctext">Medical use</span></a>
<ul>
<li class="toclevel-2"><a href="#Experimental_antidepressant_use"><span class="tocnumber">2.1</span> <span class="toctext">Experimental antidepressant use</span></a></li>
<li class="toclevel-2"><a href="#Treatment_of_addiction"><span class="tocnumber">2.2</span> <span class="toctext">Treatment of addiction</span></a></li>
<li class="toclevel-2"><a href="#Treatment_of_reflex_sympathetic_dystrophy"><span class="tocnumber">2.3</span> <span class="toctext">Treatment of reflex sympathetic dystrophy</span></a></li>
<li class="toclevel-2"><a href="#Postoperative_pain"><span class="tocnumber">2.4</span> <span class="toctext">Postoperative pain</span></a></li>
<li class="toclevel-2"><a href="#Contents_of_various_brands_of_ketamine"><span class="tocnumber">2.5</span> <span class="toctext">Contents of various brands of ketamine</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Neuropharmacology"><span class="tocnumber">3</span> <span class="toctext">Neuropharmacology</span></a></li>
<li class="toclevel-1"><a href="#Recreational_use"><span class="tocnumber">4</span> <span class="toctext">Recreational use</span></a>
<ul>
<li class="toclevel-2"><a href="#Illicit_sale"><span class="tocnumber">4.1</span> <span class="toctext">Illicit sale</span></a></li>
<li class="toclevel-2"><a href="#Methods_of_use"><span class="tocnumber">4.2</span> <span class="toctext">Methods of use</span></a></li>
<li class="toclevel-2"><a href="#Psychological_effects"><span class="tocnumber">4.3</span> <span class="toctext">Psychological effects</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Long-term_side_effects"><span class="tocnumber">5</span> <span class="toctext">Long-term side effects</span></a></li>
<li class="toclevel-1"><a href="#Pop_culture"><span class="tocnumber">6</span> <span class="toctext">Pop culture</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">7</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>Ketamine was developed by Dr. Craig Newlands of <a href="/wiki/Wayne_State_University" title="Wayne State University">Wayne State University</a>. It was then developed by Parke-Davis in 1962 as part of an effort to find a safer anesthetic alternative to <a href="/wiki/Phencyclidine" title="Phencyclidine">phencyclidine</a> (PCP), which was more likely to cause <a href="/wiki/Hallucination" title="Hallucination">hallucinations</a>, <a href="/wiki/Neurotoxicity" title="Neurotoxicity">neurotoxicity</a> and <a href="/wiki/Seizure" title="Seizure">seizures</a>. The drug was first given to <a href="/wiki/United_States" title="United States">American</a> soldiers during the <a href="/wiki/Vietnam_War" title="Vietnam War">Vietnam War</a>. It is still widely used in humans. There may be some evidence that ketamine has the potential to cause <a href="/wiki/Emergence_Phenomenon" title="Emergence Phenomenon" class="mw-redirect">emergence phenomena</a> because of the drug's possible <a href="/wiki/Psychotomimetic" title="Psychotomimetic">psychotomimetic</a> effects.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since July 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> It is also used widely in <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary medicine</a>, or as a <a href="/wiki/Battlefield_medicine" title="Battlefield medicine">battlefield</a> anesthetic in developing nations.<sup id="cite_ref-bonanno_5-0" class="reference"><a href="#cite_note-bonanno-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>Ketamine's side effects eventually made it a popular <a href="/wiki/Dissociative" title="Dissociative" class="mw-redirect">dissociative</a> in 1965. The drug was used in <a href="/wiki/Psychiatry" title="Psychiatry">psychiatric</a> and other academic research through the 1970s, culminating in 1978 with the publishing of <a href="/wiki/John_C._Lilly" title="John C. Lilly">John Lilly</a>'s <i>The Scientist</i> and Marcia Moore and Howard Alltounian's <i>Journeys into the Bright World</i>, which documented the unusual phenomenology of ketamine intoxication.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>The incidence of <a href="/wiki/Recreational_drug_use" title="Recreational drug use">recreational</a> ketamine use increased through the end of the century, especially in the context of <a href="/wiki/Rave_party" title="Rave party" class="mw-redirect">raves</a> and other parties. The increase in illicit use prompted ketamine's placement in Schedule III of the <a href="/wiki/United_States" title="United States">United States</a> <a href="/wiki/Controlled_Substance_Act" title="Controlled Substance Act" class="mw-redirect">Controlled Substance Act</a> in August 1999.<sup id="cite_ref-csa_7-0" class="reference"><a href="#cite_note-csa-7" title=""><span>[</span>8<span>]</span></a></sup> In the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, it became outlawed and labeled a <a href="/wiki/Misuse_of_Drugs_Act_1971" title="Misuse of Drugs Act 1971">Class C drug</a> on <span class="mw-formatted-date" title="2006-01-01"><span class="mw-formatted-date" title="01-01"><a href="/wiki/January_1" title="January 1">January 1</a></span>, <a href="/wiki/2006" title="2006">2006</a></span>.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup> In <a href="/wiki/Canada" title="Canada">Canada</a> ketamine is classified as a Schedule I narcotic, as of August 2005.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> In <a href="/wiki/Hong_Kong" title="Hong Kong">Hong Kong</a>, as of year 2000, ketamine is regulated under Schedule 1 of Hong Kong Chapter 134 <i>Dangerous Drugs Ordinance</i>. It can only be used legally by health professionals, for university research purposes, or with a physician's prescription.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup></p>
<p><a name="Medical_use" id="Medical_use"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=2" title="Edit section: Medical use">edit</a>]</span> <span class="mw-headline">Medical use</span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketamine_10ml_bottle.jpg" class="image" title="10ml bottles of ketamine (vet)"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/0/00/Ketamine_10ml_bottle.jpg/180px-Ketamine_10ml_bottle.jpg" width="180" height="135" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketamine_10ml_bottle.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
10ml bottles of ketamine (vet)</div>
</div>
</div>
<table bgcolor="#FFFFFF" border="1" cellpadding="3" cellspacing="0" align="right" width="167px" style="border-collapse: collapse; clear: right; margin: 0 0 0 0.5em">
<tr>
<td><b><a href="/wiki/Contraindication" title="Contraindication">Contraindications</a>:</b><br />
<ul>
<li><a href="/wiki/Alcohol" title="Alcohol">Alcohol</a></li>
<li>Other <a href="/wiki/Sedative" title="Sedative">sedatives</a></li>
<li><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">Side effects</a>:</b>
<div style="background: #ffcc99">
<p><i><b>Severe:</b></i> Impairs all senses, especially:</p>
<ul>
<li>Sight</li>
<li>Balance</li>
<li>Sense of time</li>
</ul>
</div>
<p><i><b><a href="/wiki/Cardiovascular" title="Cardiovascular" class="mw-redirect">Cardiovascular</a>:</b></i></p>
<ul>
<li>Partial depressant</li>
</ul>
<p><i><b><a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">Gastrointestinal</a>:</b></i></p>
<ul>
<li><a href="/wiki/Nausea" title="Nausea">Nausea</a></li>
</ul>
<p><i><b><a href="/wiki/Muscle" title="Muscle">Musculo</a><a href="/wiki/Skeletal" title="Skeletal" class="mw-redirect">skeletal</a>:</b></i></p>
<ul>
<li><a href="/wiki/Muscle_relaxant" title="Muscle relaxant">Relaxant</a></li>
</ul>
<p><i><b><a href="/wiki/Neurological" title="Neurological" class="mw-redirect">Neurological</a>:</b></i></p>
<ul>
<li><a href="/wiki/Analgesia" title="Analgesia" class="mw-redirect">Analgesia</a></li>
</ul>
<p><i><b><a href="/wiki/Respiration_(physiology)" title="Respiration (physiology)">Respiratory</a>:</b></i></p>
<ul>
<li>Partial depressant/stimulant</li>
</ul>
</td>
</tr>
</table>
<p>In medical settings, ketamine is usually injected intravenously or intramuscularly,<sup id="cite_ref-lankenau_11-0" class="reference"><a href="#cite_note-lankenau-11" title=""><span>[</span>12<span>]</span></a></sup> but it is also effective when <a href="/wiki/Insufflation_(medicine)" title="Insufflation (medicine)">insufflated</a>, smoked, or taken orally.<sup id="cite_ref-reboso_12-0" class="reference"><a href="#cite_note-reboso-12" title=""><span>[</span>13<span>]</span></a></sup></p>
<p>Since it suppresses breathing much less than most other available anaesthetics,<sup id="cite_ref-heshmati_13-0" class="reference"><a href="#cite_note-heshmati-13" title=""><span>[</span>14<span>]</span></a></sup> ketamine is still used in human medicine as an anesthetic, however, due to the hallucinations which may be caused by ketamine, it is not typically used as a primary anesthetic, although it is the anaesthetic of choice when reliable ventilation equipment is not available. Ketamine tends to increase heart rate and blood pressure. Because ketamine tends to increase or maintain cardiac output, it is sometimes used in anesthesia for emergency surgery when the patient's state of fluid volume status is unknown (<i>e.g.</i>, from traffic accidents). Ketamine can be used in <a href="/wiki/Podiatry" title="Podiatry">podiatry</a> and other minor surgery, and occasionally for the treatment of migraine. There is ongoing research in France, the Netherlands, Russia, Australia and the U.S. into the drug's usefulness in pain therapy, depression suppression, and for the treatment of <a href="/wiki/Alcoholism" title="Alcoholism">alcoholism</a><sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> and <a href="/wiki/Heroin" title="Heroin">heroin</a> <a href="/wiki/Addiction" title="Addiction">addiction</a>.<sup id="cite_ref-jovaisa_15-0" class="reference"><a href="#cite_note-jovaisa-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>In <a href="/wiki/Veterinary_anesthesia" title="Veterinary anesthesia">veterinary anesthesia</a>, ketamine is often used for its anesthetic and <a href="/wiki/Analgesic" title="Analgesic">analgesic</a> effects on cats, dogs, <a href="/wiki/Rabbit" title="Rabbit">rabbits</a>, <a href="/wiki/Rat" title="Rat">rats</a>, and other small animals. Veterinarians often use ketamine with sedative drugs to produce balanced anesthesia and analgesia, and as a constant rate infusion to help prevent <a href="/wiki/Pain_wind-up" title="Pain wind-up">pain wind-up</a>. Ketamine is used to manage pain among large animals, though it has less effect on <a href="/wiki/Bovine" title="Bovine" class="mw-redirect">bovines</a>. It is the primary intravenous <a href="/wiki/Anesthetic" title="Anesthetic" class="mw-redirect">anesthetic</a> agent used in equine surgery, often in conjunction with <a href="/wiki/Detomidine" title="Detomidine">detomidine</a> and <a href="/wiki/Thiopental" title="Thiopental" class="mw-redirect">thiopental</a>, or sometimes <a href="/wiki/Guaifenesin" title="Guaifenesin">guaifenesin</a>.</p>
<p>Ketamine may be used in small doses (0.1–0.5&#160;mg/kg/h) as a local anesthetic, particularly for the treatment of pain associated with movement and <a href="/wiki/Neuropathic_pain" title="Neuropathic pain" class="mw-redirect">neuropathic pain</a>.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup> It may also be used as an intravenous co-analgesic together with opiates to manage otherwise intractable pain, particularly if this pain is neuropathic (pain due to vascular insufficiency or shingles are good examples). It has the added benefit of counter-acting <a href="/wiki/Spinal_sensitization" title="Spinal sensitization" class="mw-redirect">spinal sensitization</a> or wind-up phenomena experienced with <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>. At these doses, the <a href="/wiki/Psychoactive_drug" title="Psychoactive drug">psychotropic</a> side effects are less apparent and well managed with <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>.<sup id="cite_ref-elia_17-0" class="reference"><a href="#cite_note-elia-17" title=""><span>[</span>18<span>]</span></a></sup> Ketamine is a co-analgesic, and so is most effective when used alongside a low-dose <a href="/wiki/Opioid" title="Opioid">opioid</a>; while it does have analgesic effects by itself, the higher doses required can cause disorienting side effects.<sup id="cite_ref-elia_17-1" class="reference"><a href="#cite_note-elia-17" title=""><span>[</span>18<span>]</span></a></sup> The combination of ketamine with an opioid is, however, particularly useful for pain caused by cancer.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p>The effect of ketamine on the <a href="/wiki/Respiratory_system" title="Respiratory system">respiratory</a> and <a href="/wiki/Circulatory_system" title="Circulatory system">circulatory</a> systems is different from that of other anesthetics. When used at anesthetic doses, it will usually stimulate rather than depress the circulatory system.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> It is sometimes possible to perform ketamine anesthesia without protective measures to the airways. Ketamine is also a potent <a href="/wiki/Analgesic" title="Analgesic">analgesic</a> and can be used in sub-anesthetic doses to relieve acute pain; however, its <a href="/wiki/Psychotropic" title="Psychotropic" class="mw-redirect">psychotropic</a> properties must be taken into account. Patients have reported vivid hallucinations, "going into other worlds" or "seeing <a href="/wiki/God" title="God">God</a>" while anesthetized, and these unwanted psychological side-effects have reduced the use of ketamine in human medicine. They can, however, usually be avoided by concomitant application of a sedative such as a <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepine</a>.<sup id="cite_ref-elia_17-2" class="reference"><a href="#cite_note-elia-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>Low-dose ketamine is recognized for its potential effectiveness in the treatment of <a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">complex regional pain syndrome</a> (<a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">CRPS</a>), according to a retrospective review published in the October 2004 issue of Pain Medicine.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup> Although low-dose ketamine therapy is established as a generally safe procedure, reported side effects in some patients have included hallucinations, dizziness, lightheadedness and nausea. Therefore nurses administering ketamine to patients with CRPS should only do so in a setting where a trained physician is available if needed to assess potential adverse effects on patients.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="Experimental_antidepressant_use" id="Experimental_antidepressant_use"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=3" title="Edit section: Experimental antidepressant use">edit</a>]</span> <span class="mw-headline">Experimental antidepressant use</span></h4>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:100gket.jpg" class="image" title="100g of Ketamine"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/b/b7/100gket.jpg/180px-100gket.jpg" width="180" height="230" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:100gket.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
100g of Ketamine</div>
</div>
</div>
<p>When treating patients suffering from <a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">complex regional pain syndrome</a> (CRPS) with a low-dose (subanesthetic) ketamine infusion, it was observed that some patients made a significant recovery from associated <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a>. This recovery was not formally documented, as the primary concern was the treatment of the patient's pain. It was not possible to quantify to what degree depression recovery was secondary to the patient's recovery from CRPS. Based on this result, it was thought that a low-dose (subanesthetic) infusion of ketamine was worth a trial in patients who were suffering from treatment-resistant depression without other physical or psychiatric illness.</p>
<p>Correll, <i>et al.</i> gave ketamine intravenously to patients commencing at 15–20&#160;mg/h (0.1–0.2&#160;mg/kg/h) and the dose increased until a maximum tolerated dose was achieved. This dose was assumed to be a therapeutic dose and was maintained for 5 days. Patients were able to eat, drink, watch television, or read. They could feel inebriated and/or unsteady when walking. If hallucinations occurred, the dose was to be reduced. The patients' normal medications were continued as it was feared that stopping them might result in severe depressive episodes. Before and following each treatment with ketamine, at patient clinic visits, the <a href="/wiki/Beck_Depression_Inventory" title="Beck Depression Inventory">Beck Depression Inventory</a> (BDI) and the <a href="/wiki/Hamilton_Rating_Scale_for_Depression" title="Hamilton Rating Scale for Depression">Hamilton Rating Scale for Depression</a> (HAMD-17) were obtained. Two of the patients were described with "impressive", as described by an attending doctor, improvement in depression being maintained for 12 months in patient A and recurrence at 2.5 months and 9 months in patient B.<sup id="cite_ref-pmid16533209_22-0" class="reference"><a href="#cite_note-pmid16533209-22" title=""><span>[</span>23<span>]</span></a></sup></p>
<p>The <a href="/wiki/National_Institute_of_Health" title="National Institute of Health" class="mw-redirect">National Institute of Health</a> News reports that a study of 18 patients has found that ketamine significantly improved treatment-resistant major depression within hours of injection.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup> The improvement lasted up to one week after the single dose.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> The patients in the study were previously treatment resistant, having tried an average of six other treatments that failed. NIMH director Dr. Thomas Insel said in the paper:</p>
<blockquote>
<p>"To my knowledge, this is the first report of any medication or other treatment that results in such a pronounced, rapid, prolonged response with a single dose. These were very treatment-resistant patients."</p>
</blockquote>
<p>The researchers apparently attribute the effect to ketamine being an <a href="/wiki/N-methyl-D-aspartate_receptor" title="N-methyl-D-aspartate receptor" class="mw-redirect">NMDA</a> <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">receptor antagonist</a>.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> Those findings of Zarate <i>et al.</i> corroborate earlier findings by Berman <i>et al.</i>.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> However Zarate et al. do raise some concerns about their results due to a possible lack of blinding, because of the inebriating effects of low dose ketamine infusion, and it is recommended that future studies include an active placebo.</p>
<p>The findings by Zarate et al. are confirmed by Liebrenz et al., who substantially, according to an attending doctor, helped a 55-year-old male subject with a treatment-resistant major depression and a co-occurring alcohol and <a href="/wiki/Benzodiazepine_dependence" title="Benzodiazepine dependence">benzodiazepine dependence</a> by giving an intravenous infusion of 0.5&#160;mg/kg ketamine over a period of 50 minutes and Goforth et al. who helped a patient with severe, recurrent major depressive disorder that demonstrated marked improvement within 8 hours of receiving a preoperative dose of ketamine and one treatment of <a href="/wiki/Electroconvulsive_therapy" title="Electroconvulsive therapy">electroconvulsive therapy</a> with bitemporal electrode placement.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup>&lt;<sup id="cite_ref-pmid17435569_28-0" class="reference"><a href="#cite_note-pmid17435569-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<p>However, a new study in mice by Zarate et al. shows that blocking the NMDA receptor is an intermediate step. According to this study, blocking NMDA increases the activity of another receptor, <a href="/wiki/AMPA_receptor" title="AMPA receptor">AMPA</a>, and this boost in AMPA activity is crucial for ketamine’s rapid antidepressant actions. NMDA and AMPA are receptors for the <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Glutamic_acid" title="Glutamic acid">glutamate</a>. The glutamate system has been implicated in depression recently. This is a departure from previous thinking, which had focused on <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> and <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>. The glutamate system may represent a new avenue for treatment and research.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p>Krystal et al. retrospectively compared the seizure duration, ictal EEG, and cognitive side effects of ketamine and methohexital anesthesia with ECT in 36 patients.<sup id="cite_ref-pmid12556568_30-0" class="reference"><a href="#cite_note-pmid12556568-30" title=""><span>[</span>31<span>]</span></a></sup> Ketamine was well tolerated and prolonged seizure duration overall, but particularly in those who had a seizure duration shorter than 25 seconds with methohexital at the maximum available stimulus intensity. Ketamine also increased midictal EEG slow-wave amplitude. Thus, a switch to ketamine may be useful when it is difficult to elicit a robust seizure. Faster post-treatment reorientation with ketamine may suggest a lower level of associated cognitive side effects.</p>
<p>Kudoh et al. investigated whether ketamine is suitable for depressed patients who had undergone orthopedic surgery.<sup id="cite_ref-pmid12088953_31-0" class="reference"><a href="#cite_note-pmid12088953-31" title=""><span>[</span>32<span>]</span></a></sup> They studied 70 patients with major depression and 25 patients as the control (Group C). The depressed patients were divided randomly into two groups; patients in Group A, initial HAMD 12,7 (n = 35) were induced with propofol, fentanyl, and ketamine and patients in Group B, initial HAMD 12,3 (n = 35) were induced with propofol and fentanyl. Depressed mood, suicidal tendencies, somatic anxiety, and hypochondriasis significantly decreased in Group A as compared with Group B. The group receiving ketamine also had significantly lower postoperative pain.</p>
<p>Acute administration of ketamine at the higher dose, but not <a href="/wiki/Imipramine" title="Imipramine">imipramine</a>, increased BDNF protein levels in the rat <a href="/wiki/Hippocampus" title="Hippocampus">hippocampus</a>. The increase of hippocampal BDNF protein levels induced by ketamine might be necessary to produce a rapid onset of antidepressant action.<sup id="cite_ref-pmid17884272_32-0" class="reference"><a href="#cite_note-pmid17884272-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p><a name="Treatment_of_addiction" id="Treatment_of_addiction"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=4" title="Edit section: Treatment of addiction">edit</a>]</span> <span class="mw-headline">Treatment of addiction</span></h4>
<p>The Russian doctor Evgeny Krupitsky (Clinical Director of Research for the Saint Petersburg Regional Center for Research in Addiction and Psychopharmacology) has claimed to have encouraging results by using ketamine as part of a treatment for alcohol addiction which combines psychedelic and aversive techniques.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> This method involved psychotherapy, controlled ketamine use and group therapy, and resulted in 60 of the 86 alcoholic males selected for the study remaining fully abstinent through one year of treatment. He has also treated heroin addicts and reached the conclusion that one ketamine-assisted psychotherapy session was significantly more effective than active placebo in promoting abstinence from heroin during one year without any adverse reactions. In a recently published study 59 detoxified inpatients with heroin dependence received a ketamine-assisted psychotherapy (KPT) session prior to their discharge from an addiction treatment hospital, and were then randomized into two treatment groups.</p>
<p>Participants in the first group received two addiction counseling sessions followed by two KPT sessions, (with a single im injection of 2&#160;mg/kg ketamine) with sessions scheduled on a monthly interval (multiple KPT group). Participants in the second group received two addiction counseling sessions on a monthly interval, but no additional ketamine therapy sessions (single KPT group). At one-year follow-up, survival analysis demonstrated a significantly higher rate of abstinence in the multiple KPT group. Thirteen out of 26 subjects (50%) in the multiple KPT group remained abstinent, compared to 6 out of 27 subjects (22.2%) in the single KPT group (p &lt; 0.05). No differences between groups were found in depression, anxiety, craving for heroin, or their understanding of the meaning of their lives. It was concluded that three sessions of ketamine-assisted psychotherapy are more effective than a single session for the treatment of heroin addiction.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p>In a 2007 chapter "Ketamine Psychedelic Psychotherapy" Krupitsky and Kolp summarize their work-to-date in Chapter 5 in <i>Psychedelic Medicine: New Evidence for Hallucinogens as Treatments,</i><sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup></p>
<p>Jovaisa et al. from Lithuania demonstrated attenuation of opiate withdrawal symptoms with ketamine. A total of 58 opiate-dependent patients were enrolled in a randomized, placebo-controlled, double-blind study. Patients underwent rapid opiate antagonist induction under general anesthesia. Prior to opiate antagonist induction patients were given either placebo (normal saline) or subanesthetic ketamine infusion of 0.5&#160;mg/kg/h. Ketamine group presented better control of withdrawal symptoms, which lasted beyond ketamine infusion itself. Significant differences between ketamine and Control groups were noted in anesthetic and early postanesthetic phases. There were no differences in effects on outcome after 4 months.<sup id="cite_ref-jovaisa_15-1" class="reference"><a href="#cite_note-jovaisa-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p><a name="Treatment_of_reflex_sympathetic_dystrophy" id="Treatment_of_reflex_sympathetic_dystrophy"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=5" title="Edit section: Treatment of reflex sympathetic dystrophy">edit</a>]</span> <span class="mw-headline">Treatment of reflex sympathetic dystrophy</span></h4>
<p>Ketamine is being used as an experimental and controversial treatment for <a href="/wiki/Complex_Regional_Pain_Syndrome" title="Complex Regional Pain Syndrome" class="mw-redirect">Complex Regional Pain Syndrome</a> (CRPS) also known as <a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Reflex Sympathetic Dystrophy</a> (<a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">RSD</a>). CRPS/RSD is a severe chronic pain condition characterized by sensory, <a href="/wiki/Autonomic" title="Autonomic">autonomic</a>, motor and dystrophic signs and symptoms. The pain in CRPS is continuous, it worsens over time, and it is usually disproportionate to the severity and duration of the inciting event. The hypothesis is that ketamine manipulates <a href="/wiki/NMDA" title="NMDA">NMDA</a> receptors which might reboot aberrant brain activity. There are two treatment modalities, the first consist of a low dose ketamine infusion of between 25-90&#160;mg per day, over five days either in hospital or as an outpatient. This is called the awake technique. Open label, prospective, pain journal evaluation of a 10-day infusion of intravenous ketamine (awake technique) in the CRPS patient concluded that "A four-hour ketamine infusion escalated from 40-80 mg over a 10-day period can result in a significant reduction of pain with increased mobility and a tendency to decreased autonomic dysregulation".<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p>Case notes of 33 patients whose CRPS pain was treated by the inpatient administration of a continuous subanesthetic intravenous infusion of ketamine were reviewed at Mackay Base Hospital, Queensland, Australia. A total of 33 patients with diagnoses of CRPS who had undergone ketamine treatment at least once were identified. Due to relapse, 12 of 33 patients received a second course of therapy, and two of 33 patients received a third. There was complete pain relief in 25 (76%), partial relief in six (18%), and no relief in two (6%) patients.</p>
<p>The degree of relief obtained following repeat therapy (N=12) appeared even better, as all 12 patients who received second courses of treatment experienced complete relief of their CRPS pain. The duration of relief was also impressive, as was the difference between the duration of relief obtained after the first and after the second courses of therapy. In this respect, following the first course of therapy, 54% of 33 individuals remained pain free for &gt;/=3 months and 31% remained pain free for &gt;/=6 months. After the second infusion, 58% of 12 patients experienced relief for &gt;/=1 year, while almost 33% remained pain free for &gt;3 years. The most frequent side effect observed in patients receiving this treatment was a feeling of inebriation. Hallucinations occurred in six patients. Less frequent side effects also included complaints of light-headedness, dizziness, and nausea. In four patients, an alteration in hepatic enzyme profile was noted; the infusion was terminated and the abnormality resolved thereafter. No long-term side-effects were noted.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>The second treatment modality consists of putting the patient into a medically-induced coma and given an extremely high dosage of ketamine; typically between 600-900&#160;mg.<sup id="cite_ref-cnn_rsd_coma_40-0" class="reference"><a href="#cite_note-cnn_rsd_coma-40" title=""><span>[</span>41<span>]</span></a></sup> This version, currently not allowed in the United States, is most commonly done in Germany but some treatments are now also taking place in Monterrey, Mexico. According to Dr Schwartzman, 14 cases out of 41 patients in the coma induced ketamine experiments were completely cured. "We haven't cured the original injury," he says, "but we have cured the RSD or kept it in remission. The RSD pain is gone." He added that "No one ever cured it before... In 40 years, I have never seen anything like it. These are people who were disabled and in horrible pain. Most were completely incapacitated. They go back to work, back to school, and are doing everything they used to do. Most are on no medications at all. I have taken morphine pumps out of people. You turn off the pain and reset the whole system."<sup id="cite_ref-cnn_rsd_coma_40-1" class="reference"><a href="#cite_note-cnn_rsd_coma-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>In Tuebingen, Germany Dr Kiefer treated a patient presented with a rapidly progressing contiguous spread of CRPS from a severe ligamentous wrist injury. Standard pharmacological and interventional therapy successively failed to halt the spread of CRPS from the wrist to the entire right arm. Her pain was unmanageable with all standard therapy. As a last treatment option, the patient was transferred to the intensive care unit and treated on a compassionate care basis with anesthetic doses of ketamine in gradually increasing (3-5&#160;mg/kg/h) doses in conjunction with midazolam over a period of 5 days. On the second day, edema, and discoloration began to resolve and increased spontaneous movement was noted. On day 6, symptoms completely resolved and infusions were tapered. The patient emerged from anesthesia completely free of pain and associated CRPS signs and symptoms. The patient has maintained this complete remission from CRPS for 8 years now. The psychiatric side effects of ketamine were successfully managed with the concomitant use of midazolam and resolved within 1 month of treatment.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p><a name="Postoperative_pain" id="Postoperative_pain"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=6" title="Edit section: Postoperative pain">edit</a>]</span> <span class="mw-headline">Postoperative pain</span></h4>
<p>The dissociative anesthetic effects of ketamine have also been applied within the realm of postoperative pain management. Low doses of ketamine have been found to significantly reduce morphine consumption as well as reports of nausea following abdominal surgery.<sup id="cite_ref-postopms_42-0" class="reference"><a href="#cite_note-postopms-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p><a name="Contents_of_various_brands_of_ketamine" id="Contents_of_various_brands_of_ketamine"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=7" title="Edit section: Contents of various brands of ketamine">edit</a>]</span> <span class="mw-headline">Contents of various brands of ketamine</span></h4>
<p>Ketanest S Parke Davis (Pfizer) - S enantiomer only, no preservatives<sup id="cite_ref-PMID15055891_43-0" class="reference"><a href="#cite_note-PMID15055891-43" title=""><span>[</span>44<span>]</span></a></sup></p>
<p>Ketaset® (Wyeth) - R/S ketamine and benzethonium chloride as a preservative.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p>Ketanest - S ketamine only</p>
<p>Ketalar - D/L ketamine + Phermerol® (benzethonium chloride) added as a preservative</p>
<p><a name="Neuropharmacology" id="Neuropharmacology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=8" title="Edit section: Neuropharmacology">edit</a>]</span> <span class="mw-headline">Neuropharmacology</span></h2>
<p>Ketamine was long thought to act primarily by inhibiting NMDA receptors (see below). But another NMDA receptor antagonist, MK-801, does not exert the same hypnotic effects<sup id="cite_ref-45" class="reference"><a href="#cite_note-45" title=""><span>[</span>46<span>]</span></a></sup>. It appears more likely that the hypnotic effects of ketamine are produced by inhibiting hyperpolarization-activated cyclic nucleotide-modulated (<a href="/wiki/HCN1" title="HCN1">HCN1</a>) cation channels, which mediate the "sag" current (<i>I<sub>h</sub></i> ) in neurons. Inhibition of <i>I<sub>h</sub></i> by ketamine in cultured neurons causes a hyperpolarizing shift in resting membrane potential and enhances summation of excitatory currents<sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup>. Such effects, if induced <i>in vivo</i>, would likely induce cortical oscillations reminiscent of sleep<sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup>. Most importantly, knockout of HCN1 channels in mice eliminates the hypnotic actions of ketamine<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup>.</p>
<p>Ketamine, like <a href="/wiki/Phencyclidine" title="Phencyclidine">phencyclidine</a>, is also a non-competitive <a href="/wiki/NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonist</a><sup id="cite_ref-harrison_1-1" class="reference"><a href="#cite_note-harrison-1" title=""><span>[</span>2<span>]</span></a></sup>. This <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a> opens in response to binding of the <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">glutamate</a>, and mediates the <a href="/wiki/Analgesia" title="Analgesia" class="mw-redirect">analgesic</a> (reduction of pain) effects of ketamine at low doses.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Evidence for this is reinforced by the fact that <a href="/wiki/Naloxone" title="Naloxone">naloxone</a>, an <a href="/wiki/Opioid" title="Opioid">opioid</a> antagonist, does not reverse the analgesia. Studies also seem to indicate that ketamine is "use dependent" meaning it only initiates its blocking action once a glutamate binds to the NMDA receptor.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>At high, fully anesthetic level doses, ketamine has also been found to bind to <a href="/wiki/Opioid" title="Opioid">opioid</a> mu receptors and sigma receptors.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Thus, loss of consciousness that occurs at high doses may be partially due to binding at the opioid mu and sigma receptors.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>(<i>rac</i>)-ketamine is a noncompetitive inhibitor of the α7 nAChR at clinically relevant concentrations. The preservative benzethonium chloride competitively inhibits α7 and α4β2 nAChRs at concentrations present in the clinical formulation of Ketalar.<sup id="cite_ref-pmid11606328_49-0" class="reference"><a href="#cite_note-pmid11606328-49" title=""><span>[</span>50<span>]</span></a></sup></p>
<p>Ketamine is <a href="/wiki/Racemic" title="Racemic" class="mw-redirect">racemic</a>, and its R and S <a href="/wiki/Stereoisomers" title="Stereoisomers" class="mw-redirect">stereoisomers</a> have different binding affinities: (S)-ketamine has about four times greater affinity for the PCP site of the NMDA receptor than does (R)-ketamine (in guinea pig brain).<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> <a href="/wiki/Esketamine" title="Esketamine">(S)-ketamine</a> seems to induce drowsiness more strongly than the (R) enantiomer; it is probable that (R)-ketamine is the stronger sigma agonist and so this enantiomer is likely to be responsible for the lowering of the seizure threshold that can occur with ketamine.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Since (S)-ketamine has greater analgesic effects and less hallucinogenic side effects than (R)-ketamine, the pure (S) enantiomer is sometimes preferred to the racemic mix for use in medical procedures, especially when lower doses are used for minor surgical procedures where the patient remains conscious during the operation.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<center>
<table class="gallery" cellspacing="0" cellpadding="0">
<tr>
<td>
<div class="gallerybox" style="width: 155px;">
<div class="thumb" style="padding: 13px 0; width: 150px;">
<div style="margin-left: auto; margin-right: auto; width: 120px;"><a href="/wiki/File:R-ketamine-2D-skeletal.png" class="image" title="R-ketamine-2D-skeletal.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/f/fc/R-ketamine-2D-skeletal.png/101px-R-ketamine-2D-skeletal.png" width="101" height="120" border="0" /></a></div>
</div>
<div class="gallerytext">
<center><a href="/wiki/Skeletal_formula" title="Skeletal formula">skeletal formula</a> of <i>(R)</i>-ketamine</center>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 155px;">
<div class="thumb" style="padding: 13px 0; width: 150px;">
<div style="margin-left: auto; margin-right: auto; width: 120px;"><a href="/wiki/File:R-ketamine-3D-balls.png" class="image" title="R-ketamine-3D-balls.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/82/R-ketamine-3D-balls.png/106px-R-ketamine-3D-balls.png" width="106" height="120" border="0" /></a></div>
</div>
<div class="gallerytext">
<center><a href="/wiki/Ball-and-stick_model" title="Ball-and-stick model">ball-and-stick model</a> of <i>(R)</i>-ketamine</center>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 155px;">
<div class="thumb" style="padding: 13px 0; width: 150px;">
<div style="margin-left: auto; margin-right: auto; width: 120px;"><a href="/wiki/File:S-(%2B)-ketamine-from-xtal-2D-skeletal.png" class="image" title="S-(+)-ketamine-from-xtal-2D-skeletal.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a0/S-%28%2B%29-ketamine-from-xtal-2D-skeletal.png/109px-S-%28%2B%29-ketamine-from-xtal-2D-skeletal.png" width="109" height="119" border="0" /></a></div>
</div>
<div class="gallerytext">
<center><a href="/wiki/Skeletal_formula" title="Skeletal formula">skeletal formula</a> of <i>(S)</i>-ketamine</center>
</div>
</div>
</td>
<td>
<div class="gallerybox" style="width: 155px;">
<div class="thumb" style="padding: 13px 0; width: 150px;">
<div style="margin-left: auto; margin-right: auto; width: 120px;"><a href="/wiki/File:S-(%2B)-ketamine-from-xtal-3D-balls.png" class="image" title="S-(+)-ketamine-from-xtal-3D-balls.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/b/b7/S-%28%2B%29-ketamine-from-xtal-3D-balls.png/95px-S-%28%2B%29-ketamine-from-xtal-3D-balls.png" width="95" height="120" border="0" /></a></div>
</div>
<div class="gallerytext">
<center>ball-and-stick model of <i>(S)</i>-ketamine</center>
</div>
</div>
</td>
</tr>
</table>
</center>
<p>The effects seem to take place mainly in the <a href="/wiki/Hippocampus" title="Hippocampus">hippocampal formation</a> and in the <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a>. This evidence, along with the NMDA receptor's connection with the memory formation process, explains ketamine's profound effects on <a href="/wiki/Memory" title="Memory">memory</a> and thought. These effects inhibit the filtering function of the brain and may mirror the sensory overload associated with <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and <a href="/wiki/Near_death_experience" title="Near death experience">near death experiences</a>.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>The local anesthetic effects are likely from the blocking action of ketamine on <a href="/wiki/Sodium_channel" title="Sodium channel">sodium channels</a>.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup> Its <i>in vitro</i> blocking potency of sodium channels in the resting state is similar to that of <a href="/wiki/Lidocaine" title="Lidocaine">lidocaine</a>.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup></p>
<p>Ketamine has a well-documented neuroprotective effect against ischemic brain-injury and glutamate induced brain injury.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup> One hypothesis of its working mechanism in case of chronic pain management and depression is that it works as an antidote to an overactivity in glutamergic brain circuits.</p>
<p><a name="Recreational_use" id="Recreational_use"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=9" title="Edit section: Recreational use">edit</a>]</span> <span class="mw-headline">Recreational use</span></h2>
<p><a name="Illicit_sale" id="Illicit_sale"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=10" title="Edit section: Illicit sale">edit</a>]</span> <span class="mw-headline">Illicit sale</span></h3>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Question_book-new.svg" class="image" title="Question book-new.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This section <b>needs additional <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a>.</b> Please help <a href="http://en.wikipedia.org/w/index.php?title=Ketamine&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Ketamine&amp;action=edit" rel="nofollow">improve this article</a> by adding <a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources">reliable references</a> (ideally, using <i><a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">inline citations</a></i>). Unsourced material may be <a href="/wiki/Template:Fact" title="Template:Fact">challenged</a> and <a href="/wiki/Wikipedia:BURDEN" title="Wikipedia:BURDEN" class="mw-redirect">removed</a>. <small><i>(December 2008)</i></small></td>
</tr>
</table>
<div class="thumb tleft">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketamine_Crystals.jpg" class="image" title="10 ml bottle of liquid ketamine drying into crystals"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/30/Ketamine_Crystals.jpg/180px-Ketamine_Crystals.jpg" width="180" height="135" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketamine_Crystals.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
10 ml bottle of liquid ketamine drying into crystals</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketamine.JPG" class="image" title="500mg Ketamine Hydrochloride"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/37/Ketamine.JPG/180px-Ketamine.JPG" width="180" height="135" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketamine.JPG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
500mg Ketamine Hydrochloride</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketaminehydrochloride.jpg" class="image" title="Ketamine dried and scraped"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/b/be/Ketaminehydrochloride.jpg/180px-Ketaminehydrochloride.jpg" width="180" height="123" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketaminehydrochloride.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Ketamine dried and scraped</div>
</div>
</div>
<p>Ketamine sold illicitly comes from diverted legitimate supplies and semi-legitimate suppliers, or theft, primarily from veterinary clinics. Most of the world's illicit ketamine comes from Asia-based pharmaceutical manufacturers, who often willingly sell it to Western individuals, who then sell it to users. This way, many ounces or even kilos of pharmaceutical ketamine are sold and shipped in each transaction by legitimate Asian producers, who will sometimes relabel the packaging before shipping with names of unregulated chemicals, making it harder for customs to discover the shipments. The many commercial advertisement websites aimed at companies who are looking to import or export products has made it a lot easier for individuals to buy ketamine over the Internet. Until recent years ketamine wasn't regulated in most countries, and customs and police authorities were powerless to stop the import of bulk pharmaceutical ketamine from Asian manufacturers; though this has changed due to the rising number of reports of use/abuse of ketamine, prompting countries to regulate the drug. Chinese authorities tried to regulate the production and sale of ketamine more as well in recent years, and several large quantities of ketamine meant for illicit sale were seized by authorities. In the US near its border with Mexico, the drug is most commonly acquired in Mexico, where it can be bought over the counter in veterinary clinics, and smuggled across the border.</p>
<p>In 2003, <a href="/wiki/Operation_TKO" title="Operation TKO">Operation TKO</a><sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup> was a probe conducted by the U.S. <a href="/wiki/Drug_Enforcement_Agency" title="Drug Enforcement Agency" class="mw-redirect">Drug Enforcement Agency</a> (DEA). As a result of operation TKO, U.S. and Mexican authorities shut down the Mexico City company Laboratorios Ttokkyo, which was the biggest producer of ketamine in Mexico. According to the DEA, over 80% of ketamine seized in the U.S. is of Mexican origin.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> Expert Committee on Drug Dependence, in its thirty-third report (2003)<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup>, recommended research into its recreational use/misuse due to growing concerns about its rising popularity in Europe, Asia and North America. This is due in part to its prevention of depression.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup></p>
<p>In <a href="/wiki/E_for_Ecstasy" title="E for Ecstasy">E for Ecstasy</a><sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup> (a book examining the uses of the street drug <a href="/wiki/Methylenedioxymethamphetamine" title="Methylenedioxymethamphetamine">Ecstasy</a> in the UK) the writer, activist and Ecstasy advocate <a href="/wiki/Nicholas_Saunders_(activist)" title="Nicholas Saunders (activist)">Nicholas Saunders</a> highlighted test results showing that certain consignments of the drug also contained ketamine. Consignments of Ecstasy known as "Strawberry" contained what Saunders described as a "potentially dangerous combination of ketamine, <a href="/wiki/Ephedrine" title="Ephedrine">ephedrine</a> and <a href="/wiki/Selegiline" title="Selegiline">selegiline</a>," as did a consignment of "Sitting Duck" Ecstasy tablets.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p><a name="Methods_of_use" id="Methods_of_use"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=11" title="Edit section: Methods of use">edit</a>]</span> <span class="mw-headline">Methods of use</span></h3>
<p>Ketamine is sold in either powdered or liquid form. In powdered form, its appearance is similar to that of <a href="/wiki/Cocaine" title="Cocaine">cocaine</a> and it can be insufflated, injected, or placed in beverages. It is also possible to smoke the drug in a joint or pipe, usually mixed with marijuana and tobacco. The smoke has a distinctive bitter taste but the effects of the high hit much faster than when insufflated, ingested or injected <a href="/wiki/Intramuscular_injection" title="Intramuscular injection">intramuscularly</a>. Oral use usually requires more material, but results in a longer trip. However, when administered orally, ketamine is rapidly metabolised to <a href="/w/index.php?title=Norketamine&amp;action=edit&amp;redlink=1" class="new" title="Norketamine (page does not exist)">norketamine</a>, which possesses sedating effects; this route of administration is unlikely to produce a dissociative state characteristic of ketamine unless very high doses (500&#160;mg+) are ingested. <sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup> Intravenous self-injection of ketamine is very dangerous.</p>
<p><a name="Psychological_effects" id="Psychological_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=12" title="Edit section: Psychological effects">edit</a>]</span> <span class="mw-headline">Psychological effects</span></h3>
<p>Ketamine produces effects similar to <a href="/wiki/Phencyclidine" title="Phencyclidine">PCP</a> and <a href="/wiki/Dextromethorphan" title="Dextromethorphan">DXM</a>. Unlike the other well known dissociatives PCP and DXM, ketamine is very short acting, its <a href="/wiki/Psychedelics,_dissociatives_and_deliriants" title="Psychedelics, dissociatives and deliriants">hallucinatory</a> effects lasting fifteen minutes when insufflated or injected and up to an hour when ingested, the total experience lasting no more than a couple of hours. <sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup> Like other dissociative anaesthetics, hallucinations caused by ketamine are fundamentally different from those caused by <a href="/wiki/Tryptamine" title="Tryptamine">tryptamines</a> and <a href="/wiki/Phenethylamine" title="Phenethylamine">phenethylamines</a>. At low doses, hallucinations are only seen when one is in a dark room with one's eyes closed, while at medium to high doses the effects are far more intense and obvious. <sup id="cite_ref-61" class="reference"><a href="#cite_note-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p>Ketamine produces a dissociative state, characterised by a sense of detachment from one's physical body and the external world which is known as <a href="/wiki/Depersonalization" title="Depersonalization">depersonalization</a> and <a href="/wiki/Derealization" title="Derealization">derealization</a>.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62" title=""><span>[</span>63<span>]</span></a></sup> At sufficiently high doses (e.g. 150&#160;mg intramuscular), users may experience what is coined the "<a href="/wiki/K-hole" title="K-hole">K-hole</a>", a state of dissociation whose effects are thought to mimic the phenomenology of schizophrenia.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup>. Users may experience worlds or dimensions that are ineffable, all the while being completely unaware of their individual identities or the external world. Users have reported intense hallucinations including visual hallucinations, perceptions of falling, fast and gradual movement and flying, 'seeing God', feeling connected to other users, objects and the cosmos, experiencing psychic connections, and shared hallucinations and thoughts with adjacent users.</p>
<p>Users may feel as though their perceptions are located so deep inside the mind that the real world seems distant (hence the use of a "hole" to describe the experience). Some users may not remember this part of the experience after regaining consciousness, in the same way that a person may forget a dream. Owing to the role of the NMDA receptor in long-term potentiation, this may be due to disturbances in memory formation. The "re-integration" process is slow, and the user gradually becomes aware of surroundings. At first, users may not remember their own names, or even know that they are human, or what that means. Movement is extremely difficult, and a user may not be aware that he or she has a body at all.</p>
<p><a name="Long-term_side_effects" id="Long-term_side_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=13" title="Edit section: Long-term side effects">edit</a>]</span> <span class="mw-headline">Long-term side effects</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Olney%27s_lesions" title="Olney's lesions">Olney's lesions</a></div>
<p>In 1989, psychiatry professor John Olney reported that ketamine caused reversible changes in two small areas of the rat brain. 40&#160;mg/kg resulted in fluid-filled cavities ("vacuoles") appearing inside cells. The cavities disappeared after several days, unless high doses of the far more toxic PCP or close relative MK801 were repeatedly given, in which case some cell death was seen. Roland Auer injected monkeys with MK801 and was unable to produce any vacuoles. When Auer was asked in 1998 whether persons undergoing anesthesia with Ketalar were at risk of these changes, his reply was that he doubted that it was even a remote possibility because of fundamental differences in metabolism between the rat and human brain. Ketamine can block excitotoxicity (brain damage due to low oxygen, low sugar, epilepsy, trauma, etc) but it can also excite the brain at low doses by switching off the inhibitory system. Why this isn't damaging in monkeys and humans probably lies in the fact that ketamine binds to an increasingly wide range of different receptors as the dose level rises, and some of these receptors act to shut down the excitement. In humans, by the time a potentially toxic dose is reached, the "excitement window" has been passed and the drug is starting to activate other systems that switch cells off again, a result of ketamine's promiscuity that improves its safety relative to MK801. MK801 binds very specifically to N-P receptors. The other part of the explanation is that rats have rates of brain metabolism that are almost twice as high as those in humans to start with. It is because of this higher base rate of metabolism that ketamine causes over-excitement in rats at doses below those at which it activates shutdown systems.”<sup id="cite_ref-64" class="reference"><a href="#cite_note-64" title=""><span>[</span>65<span>]</span></a></sup><sup id="cite_ref-dxm_health_65-0" class="reference"><a href="#cite_note-dxm_health-65" title=""><span>[</span>66<span>]</span></a></sup><sup id="cite_ref-Tryba_et_al_66-0" class="reference"><a href="#cite_note-Tryba_et_al-66" title=""><span>[</span>67<span>]</span></a></sup></p>
<p>Vutskits et al. from Geneva showed that short-term exposure of cultures to ketamine at concentrations of ≥ 20 μg/mL leads to a significant loss of differentiated cells and that non-cell death-inducing concentrations of ketamine (10 μg/mL) can still initiate long-term alterations of dendritic arbor in differentiated neurons, including dendritic retraction and branching point elimination. They also demonstrated that chronic (&gt;24 h) administration of ketamine at concentrations as low as 0.01 μg/mL can interfere with the maintenance of dendritic arbor architecture. These results raise the possibility that chronic exposure to low, subanesthetic concentrations of ketamine, while not affecting cell survival, could still impair neuronal morphology and thus might lead to dysfunctions of neural networks.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67" title=""><span>[</span>68<span>]</span></a></sup></p>
<p>There is a long list of medicines that could counteract these potential toxic effects, including <a href="/wiki/Clonidine" title="Clonidine">clonidine</a>, <a href="/wiki/Anticholinergics" title="Anticholinergics" class="mw-redirect">anticholinergics</a>, <a href="/wiki/Benzodiazepines" title="Benzodiazepines" class="mw-redirect">benzodiazepines</a>, <a href="/wiki/Barbiturates" title="Barbiturates" class="mw-redirect">barbiturates</a> and <a href="/wiki/Risperidone" title="Risperidone">risperidone</a>.<sup id="cite_ref-dxm_health_65-1" class="reference"><a href="#cite_note-dxm_health-65" title=""><span>[</span>66<span>]</span></a></sup><sup id="cite_ref-Tryba_et_al_66-1" class="reference"><a href="#cite_note-Tryba_et_al-66" title=""><span>[</span>67<span>]</span></a></sup> <sup id="cite_ref-68" class="reference"><a href="#cite_note-68" title=""><span>[</span>69<span>]</span></a></sup></p>
<p>A study in <a href="/wiki/Bristol" title="Bristol">Bristol</a> reported in the British Medical Journal on <span class="mw-formatted-date" title="2008-05-03"><a href="/wiki/May_3" title="May 3">3 May</a> <a href="/wiki/2008" title="2008">2008</a></span> linked urinary tract disease with ketamine use. Symptoms reported by users include an increased need to urinate, passing blood in urine, leakage of urine and pain on urination. These symptoms are associated with the scarification of the bladder lining, which leads to a shrunken bladder, <a href="/wiki/Erythema" title="Erythema">erythema</a>, and contact bleeding, and can then move to the ureters and damage the kidneys. <sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup><sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> In a study of 9 daily ketamine users, Shahani et al. found "marked thickening of the bladder wall, a small capacity, and perivesicular stranding, consistent with severe inflammation. At cystoscopy, all patients had severe ulcerative cystitis. Biopsies in 4 patients revealed epithelial denudation and inflammation with a mild eosinophilic infiltrate. Cessation of ketamine use, with the addition of <a href="/wiki/Pentosan_polysulfate" title="Pentosan polysulfate">pentosan polysulfate</a>, appeared to provide some symptomatic relief."<sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup><sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Many long term users report "K-Pains" or "Ketamine cramps" the exact cause of these are unknown but with extended use users report extreme pain in their lower abdomen. Heavy users report a rapid increase in tolerance with extended use and a line which might leave one user passed out may have no effect on a more experienced user.</p>
<p><a name="Pop_culture" id="Pop_culture"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=14" title="Edit section: Pop culture">edit</a>]</span> <span class="mw-headline">Pop culture</span></h2>
<p>Referred to in the song "<a href="/wiki/Special_K_(song)" title="Special K (song)">Special K</a>" by Placebo; "K-Hole" by <a href="/wiki/CocoRosie" title="CocoRosie">Cocorosie</a>; "Kids of the K-Hole" by <a href="/wiki/NOFX" title="NOFX">NOFX</a>; "Lost in the K-Hole" by <a href="/wiki/The_Chemical_Brothers" title="The Chemical Brothers">The Chemical Brothers</a>; "Dissassociative" by <a href="/wiki/Marilyn_Manson" title="Marilyn Manson">Marilyn Manson</a>; "K Horse" by <a href="/wiki/Head_Automatica" title="Head Automatica">Head Automatica</a>; "Pink Tarantulas" by <a href="/wiki/The_Blood_Brothers" title="The Blood Brothers" class="mw-redirect">The Blood Brothers</a>; "Get ready for the K-hole" by <a href="/wiki/Kissy_Sell_Out" title="Kissy Sell Out">Kissy Sell Out</a>; "Plague (we need no victims) by <a href="/wiki/Lola_Ray" title="Lola Ray">Lola Ray</a>; "Ketamine" by <a href="/wiki/Get_Back_Loretta" title="Get Back Loretta">Get Back Loretta</a>; and "K-Hole" by <a href="/wiki/Silver_Jews" title="Silver Jews">Silver Jews</a>. Hallucination experiences have also been the reference to songs written by Goodnight And I Wish*, including 'A Lucid Dream', and, 'Norlington Works', a song based on a group of friends living within a factory in east London over the summer of 2008, and the effects that the drug has on the mind.</p>
<p>K is also a drug used by the main characters throughout the novel <i>Christlike</i> by <a href="/wiki/Emanuel_Xavier" title="Emanuel Xavier">Emanuel Xavier</a> and also used by Darby Crash of the band The Germs.</p>
<p>Ketamine is the drug used by the characters of the graphic novel "Effing Brutal".</p>
<p>In the Off-Broadway musical <i><a href="/wiki/Bare:_a_pop_opera" title="Bare: a pop opera">bare: a pop opera</a></i>, students at a Catholic boarding school take K at a rave to "enhance" their "X experience". The effects of the drug are described in the song "Wonderland". <sup id="cite_ref-71" class="reference"><a href="#cite_note-71" title=""><span>[</span>72<span>]</span></a></sup></p>
<p>The title character of the TV series <a href="/wiki/House_(TV_series)" title="House (TV series)">House</a> requested an experimental Ketamine treatment that would reduce the chronic pain resulting from a leg <a href="/wiki/Infarction" title="Infarction">infarction</a>.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=15" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Psychedelics,_dissociatives_and_deliriants" title="Psychedelics, dissociatives and deliriants">Psychedelics, dissociatives and deliriants</a></li>
<li><a href="/wiki/Psychoactive_drug" title="Psychoactive drug">Psychoactive drug</a></li>
<li><a href="/wiki/Dissociation" title="Dissociation">Dissociation</a></li>
<li><a href="/wiki/Depersonalization" title="Depersonalization">Depersonalization</a></li>
<li><a href="/wiki/Derealization" title="Derealization">Derealization</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=16" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2C9 and CYP2B6 in N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 2002; 30: 853–8</li>
<li id="cite_note-harrison-1">^ <a href="#cite_ref-harrison_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-harrison_1-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHarrison_N.2C_Simmonds_M1985">Harrison N, Simmonds M (1985). "Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex". <i>Br J Pharmacol</i> <b>84</b> (2): 381–91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2858237" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2858237">PMID 2858237</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Quantitative+studies+on+some+antagonists+of+N-methyl+D-aspartate+in+slices+of+rat+cerebral+cortex&amp;rft.jtitle=Br+J+Pharmacol&amp;rft.aulast=Harrison+N%2C+Simmonds+M&amp;rft.au=Harrison+N%2C+Simmonds+M&amp;rft.date=1985&amp;rft.volume=84&amp;rft.issue=2&amp;rft.pages=381%E2%80%9391&amp;rft_id=info:pmid/2858237&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBergman_S1999">Bergman S (1999). "Ketamine: review of its pharmacology and its use in pediatric anesthesia". <i>Anesth Prog</i> <b>46</b> (1): 10–20. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10551055" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10551055">PMID 10551055</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine%3A+review+of+its+pharmacology+and+its+use+in+pediatric+anesthesia&amp;rft.jtitle=Anesth+Prog&amp;rft.aulast=Bergman+S&amp;rft.au=Bergman+S&amp;rft.date=1999&amp;rft.volume=46&amp;rft.issue=1&amp;rft.pages=10%E2%80%9320&amp;rft_id=info:pmid/10551055&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> Kruger AD. Current aspects of using ketamine in childhood. Anaesthesiologie und Reanimation. 1998;23(3):64-71.</li>
<li id="cite_note-essentialWHO-4"><b><a href="#cite_ref-essentialWHO_4-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf" class="external text" title="http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf" rel="nofollow">"WHO Model List of Essential Medicines"</a> (PDF). World Health Organization. March 2005<span class="printonly">. <a href="http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf" class="external free" title="http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf" rel="nofollow">http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf</a></span><span class="reference-accessdate">. Retrieved on 2006-03-12</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=WHO+Model+List+of+Essential+Medicines&amp;rft.atitle=&amp;rft.date=March+2005&amp;rft.pub=World+Health+Organization&amp;rft_id=http%3A%2F%2Fwhqlibdoc.who.int%2Fhq%2F2005%2Fa87017_eng.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-bonanno-5"><b><a href="#cite_ref-bonanno_5-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBonanno_F2002">Bonanno F (2002). "Ketamine in war/tropical surgery (a final tribute to the racemic mixture)". <i>Injury</i> <b>33</b> (4): 323–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0020-1383%2801%2900209-1" class="external text" title="http://dx.doi.org/10.1016%2FS0020-1383%2801%2900209-1" rel="nofollow">10.1016/S0020-1383(01)00209-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12091028" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12091028">PMID 12091028</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine+in+war%2Ftropical+surgery+%28a+final+tribute+to+the+racemic+mixture%29&amp;rft.jtitle=Injury&amp;rft.aulast=Bonanno+F&amp;rft.au=Bonanno+F&amp;rft.date=2002&amp;rft.volume=33&amp;rft.issue=4&amp;rft.pages=323%E2%80%937&amp;rft_id=info:doi/10.1016%2FS0020-1383%2801%2900209-1&amp;rft_id=info:pmid/12091028&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <a href="http://www.futurehi.net/docs/journeys/JourneysBrightWorld.html" class="external text" title="http://www.futurehi.net/docs/journeys/JourneysBrightWorld.html" rel="nofollow">Marcia Moore - Journeys into the Bright World</a></li>
<li id="cite_note-csa-7"><b><a href="#cite_ref-csa_7-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.anestesia.com.mx/articulo/keta.html" class="external text" title="http://www.anestesia.com.mx/articulo/keta.html" rel="nofollow">"Ketamine - Schedule III of The Controlled Substances Act (CSA)"</a>. Anestesiología Mexicana en Internet<span class="printonly">. <a href="http://www.anestesia.com.mx/articulo/keta.html" class="external free" title="http://www.anestesia.com.mx/articulo/keta.html" rel="nofollow">http://www.anestesia.com.mx/articulo/keta.html</a></span><span class="reference-accessdate">. Retrieved on 2006-12-22</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Ketamine+-+Schedule+III+of+The+Controlled+Substances+Act+%28CSA%29&amp;rft.atitle=&amp;rft.pub=Anestesiolog%C3%ADa+Mexicana+en+Internet&amp;rft_id=http%3A%2F%2Fwww.anestesia.com.mx%2Farticulo%2Fketa.html&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <a href="http://news.bbc.co.uk/2/hi/uk_news/4564606.stm" class="external text" title="http://news.bbc.co.uk/2/hi/uk_news/4564606.stm" rel="nofollow">BBC NEWS | UK | Club 'horse' drug to be outlawed</a></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <a href="http://laws.justice.gc.ca/en/C-38.8/229687.html#rid-229689" class="external text" title="http://laws.justice.gc.ca/en/C-38.8/229687.html#rid-229689" rel="nofollow">Controlled Drugs and Substances Act</a></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <a href="http://www.info.gov.hk/gia/general/200011/22/1122170.htm" class="external text" title="http://www.info.gov.hk/gia/general/200011/22/1122170.htm" rel="nofollow">Government to tighten control on Ketamine</a></li>
<li id="cite_note-lankenau-11"><b><a href="#cite_ref-lankenau_11-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLankenau_S.2C_Sanders_B.2C_Bloom_J.2C_Hathazi_D.2C_Alarcon_E.2C_Tortu_S.2C_Clatts_M2007">Lankenau S, Sanders B, Bloom J, Hathazi D, Alarcon E, Tortu S, Clatts M (2007). "First injection of ketamine among young injection drug users (IDUs) in three U.S. cities". <i>Drug Alcohol Depend</i> <b>87</b> (2-3): 183–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.drugalcdep.2006.08.015" class="external text" title="http://dx.doi.org/10.1016%2Fj.drugalcdep.2006.08.015" rel="nofollow">10.1016/j.drugalcdep.2006.08.015</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16979848" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16979848">PMID 16979848</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=First+injection+of+ketamine+among+young+injection+drug+users+%28IDUs%29+in+three+U.S.+cities&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.aulast=Lankenau+S%2C+Sanders+B%2C+Bloom+J%2C+Hathazi+D%2C+Alarcon+E%2C+Tortu+S%2C+Clatts+M&amp;rft.au=Lankenau+S%2C+Sanders+B%2C+Bloom+J%2C+Hathazi+D%2C+Alarcon+E%2C+Tortu+S%2C+Clatts+M&amp;rft.date=2007&amp;rft.volume=87&amp;rft.issue=2-3&amp;rft.pages=183%E2%80%9393&amp;rft_id=info:doi/10.1016%2Fj.drugalcdep.2006.08.015&amp;rft_id=info:pmid/16979848&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-reboso-12"><b><a href="#cite_ref-reboso_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFReboso_Morales_J.2C_Gonz.C3.A1lez_Miranda_F1999">Reboso Morales J, González Miranda F (1999). "[Ketamine]". <i>Rev Esp Anestesiol Reanim</i> <b>46</b> (3): 111–22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10228376" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10228376">PMID 10228376</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BKetamine%5D&amp;rft.jtitle=Rev+Esp+Anestesiol+Reanim&amp;rft.aulast=Reboso+Morales+J%2C+Gonz%C3%A1lez+Miranda+F&amp;rft.au=Reboso+Morales+J%2C+Gonz%C3%A1lez+Miranda+F&amp;rft.date=1999&amp;rft.volume=46&amp;rft.issue=3&amp;rft.pages=111%E2%80%9322&amp;rft_id=info:pmid/10228376&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-heshmati-13"><b><a href="#cite_ref-heshmati_13-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHeshmati_F.2C_Zeinali_M.2C_Noroozinia_H.2C_Abbacivash_R.2C_Mahoori_A2003">Heshmati F, Zeinali M, Noroozinia H, Abbacivash R, Mahoori A (2003). "Use of ketamine in severe status asthmaticus in intensive care unit". <i>Iran J Allergy Asthma Immunol</i> <b>2</b> (4): 175–80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17301376" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17301376">PMID 17301376</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+ketamine+in+severe+status+asthmaticus+in+intensive+care+unit&amp;rft.jtitle=Iran+J+Allergy+Asthma+Immunol&amp;rft.aulast=Heshmati+F%2C+Zeinali+M%2C+Noroozinia+H%2C+Abbacivash+R%2C+Mahoori+A&amp;rft.au=Heshmati+F%2C+Zeinali+M%2C+Noroozinia+H%2C+Abbacivash+R%2C+Mahoori+A&amp;rft.date=2003&amp;rft.volume=2&amp;rft.issue=4&amp;rft.pages=175%E2%80%9380&amp;rft_id=info:pmid/17301376&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKrystal_J.2C_Madonick_S.2C_Perry_E.2C_Gueorguieva_R.2C_Brush_L.2C_Wray_Y.2C_Belger_A.2C_D.27Souza_D2006">Krystal J, Madonick S, Perry E, Gueorguieva R, Brush L, Wray Y, Belger A, D'Souza D (2006). "Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism". <i>Neuropsychopharmacology</i> <b>31</b> (8): 1793–800. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300994" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300994" rel="nofollow">10.1038/sj.npp.1300994</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16395307" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16395307">PMID 16395307</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Potentiation+of+low+dose+ketamine+effects+by+naltrexone%3A+potential+implications+for+the+pharmacotherapy+of+alcoholism&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Krystal+J%2C+Madonick+S%2C+Perry+E%2C+Gueorguieva+R%2C+Brush+L%2C+Wray+Y%2C+Belger+A%2C+D%27Souza+D&amp;rft.au=Krystal+J%2C+Madonick+S%2C+Perry+E%2C+Gueorguieva+R%2C+Brush+L%2C+Wray+Y%2C+Belger+A%2C+D%27Souza+D&amp;rft.date=2006&amp;rft.volume=31&amp;rft.issue=8&amp;rft.pages=1793%E2%80%93800&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300994&amp;rft_id=info:pmid/16395307&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-jovaisa-15">^ <a href="#cite_ref-jovaisa_15-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-jovaisa_15-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJovaisa_T.2C_Laurinenas_G.2C_Vosylius_S.2C_Sipylaite_J.2C_Badaras_R.2C_Ivaskevicius_J2006">Jovaisa T, Laurinenas G, Vosylius S, Sipylaite J, Badaras R, Ivaskevicius J (2006). "Effects of ketamine on precipitated opiate withdrawal". <i>Medicina (Kaunas)</i> <b>42</b> (8): 625–34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16963828" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16963828">PMID 16963828</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+ketamine+on+precipitated+opiate+withdrawal&amp;rft.jtitle=Medicina+%28Kaunas%29&amp;rft.aulast=Jovaisa+T%2C+Laurinenas+G%2C+Vosylius+S%2C+Sipylaite+J%2C+Badaras+R%2C+Ivaskevicius+J&amp;rft.au=Jovaisa+T%2C+Laurinenas+G%2C+Vosylius+S%2C+Sipylaite+J%2C+Badaras+R%2C+Ivaskevicius+J&amp;rft.date=2006&amp;rft.volume=42&amp;rft.issue=8&amp;rft.pages=625%E2%80%9334&amp;rft_id=info:pmid/16963828&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLunch_ish_M.2C_Clark_A.2C_Sawynok_J.2C_Sullivan_M2005">Lunch ish M, Clark A, Sawynok J, Sullivan M (2005). "Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study". <i>J Pain</i> <b>6</b> (10): 644–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jpain.2005.04.008" class="external text" title="http://dx.doi.org/10.1016%2Fj.jpain.2005.04.008" rel="nofollow">10.1016/j.jpain.2005.04.008</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16202956" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16202956">PMID 16202956</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Topical+amitriptyline+and+ketamine+in+neuropathic+pain+syndromes%3A+an+open-label+study&amp;rft.jtitle=J+Pain&amp;rft.aulast=Lunch+ish+M%2C+Clark+A%2C+Sawynok+J%2C+Sullivan+M&amp;rft.au=Lunch+ish+M%2C+Clark+A%2C+Sawynok+J%2C+Sullivan+M&amp;rft.date=2005&amp;rft.volume=6&amp;rft.issue=10&amp;rft.pages=644%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.jpain.2005.04.008&amp;rft_id=info:pmid/16202956&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-elia-17">^ <a href="#cite_ref-elia_17-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-elia_17-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-elia_17-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFElia_N.2C_Tram.C3.A8r_M2005">Elia N, Tramèr M (2005). "Ketamine and postoperative pain--a quantitative systematic review of randomised trials". <i>Pain</i> <b>113</b> (1-2): 61–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pain.2004.09.036" class="external text" title="http://dx.doi.org/10.1016%2Fj.pain.2004.09.036" rel="nofollow">10.1016/j.pain.2004.09.036</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15621365" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15621365">PMID 15621365</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine+and+postoperative+pain--a+quantitative+systematic+review+of+randomised+trials&amp;rft.jtitle=Pain&amp;rft.aulast=Elia+N%2C+Tram%C3%A8r+M&amp;rft.au=Elia+N%2C+Tram%C3%A8r+M&amp;rft.date=2005&amp;rft.volume=113&amp;rft.issue=1-2&amp;rft.pages=61%E2%80%9370&amp;rft_id=info:doi/10.1016%2Fj.pain.2004.09.036&amp;rft_id=info:pmid/15621365&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSaito_O.2C_Aoe_T.2C_Kozikowski_A.2C_Sarva_J.2C_Neale_J.2C_Yamamoto_T2006">Saito O, Aoe T, Kozikowski A, Sarva J, Neale J, Yamamoto T (2006). "Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain". <i>Can J Anaesth</i> <b>53</b> (9): 891–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16960267" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16960267">PMID 16960267</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine+and+N-acetylaspartylglutamate+peptidase+inhibitor+exert+analgesia+in+bone+cancer+pain&amp;rft.jtitle=Can+J+Anaesth&amp;rft.aulast=Saito+O%2C+Aoe+T%2C+Kozikowski+A%2C+Sarva+J%2C+Neale+J%2C+Yamamoto+T&amp;rft.au=Saito+O%2C+Aoe+T%2C+Kozikowski+A%2C+Sarva+J%2C+Neale+J%2C+Yamamoto+T&amp;rft.date=2006&amp;rft.volume=53&amp;rft.issue=9&amp;rft.pages=891%E2%80%938&amp;rft_id=info:pmid/16960267&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAdams_H1997">Adams H (1997). "[S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]". <i>Anaesthesist</i> <b>46</b> (12): 1081–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9451493" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9451493">PMID 9451493</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BS-%28%2B%29-ketamine.+Circulatory+interactions+during+total+intravenous+anesthesia+and+analgesia-sedation%5D&amp;rft.jtitle=Anaesthesist&amp;rft.aulast=Adams+H&amp;rft.au=Adams+H&amp;rft.date=1997&amp;rft.volume=46&amp;rft.issue=12&amp;rft.pages=1081%E2%80%937&amp;rft_id=info:pmid/9451493&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <a href="http://www.medscape.com/viewarticle/490806" class="external text" title="http://www.medscape.com/viewarticle/490806" rel="nofollow">Log In Problems</a></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <a href="http://www.blackwellpublishing.com/press/pressitem.asp?ref=180" class="external text" title="http://www.blackwellpublishing.com/press/pressitem.asp?ref=180" rel="nofollow">Blackwell Publishing Press Room</a></li>
<li id="cite_note-pmid16533209-22"><b><a href="#cite_ref-pmid16533209_22-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCorrell_GE.2C_Futter_GE2006">Correll GE, Futter GE (2006). "Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions". <i>Pain Med</i> <b>7</b> (1): 92–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1526-4637.2006.00101.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1526-4637.2006.00101.x" rel="nofollow">10.1111/j.1526-4637.2006.00101.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16533209" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16533209">PMID 16533209</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Two+case+studies+of+patients+with+major+depressive+disorder+given+low-dose+%28subanesthetic%29+ketamine+infusions&amp;rft.jtitle=Pain+Med&amp;rft.aulast=Correll+GE%2C+Futter+GE&amp;rft.au=Correll+GE%2C+Futter+GE&amp;rft.date=2006&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=92%E2%80%935&amp;rft_id=info:doi/10.1111%2Fj.1526-4637.2006.00101.x&amp;rft_id=info:pmid/16533209&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <a href="http://www.nih.gov/news/pr/aug2006/nimh-07b.htm" class="external text" title="http://www.nih.gov/news/pr/aug2006/nimh-07b.htm" rel="nofollow">NIH. "Experimental Medication Kicks Depression in Hours Instead of Weeks"</a> <i>NIH News</i>, <span class="mw-formatted-date" title="2006-08-07"><span class="mw-formatted-date" title="08-07"><a href="/wiki/August_7" title="August 7">August 7</a></span>, <a href="/wiki/2006" title="2006">2006</a></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> Khamsi, R. <a href="http://www.newscientist.com/channel/health/dn9696.html" class="external text" title="http://www.newscientist.com/channel/health/dn9696.html" rel="nofollow">"Ketamine relieves depression within hours"</a> <i><a href="/wiki/New_Scientist" title="New Scientist">New Scientist</a></i>, <span class="mw-formatted-date" title="2006-08-08"><a href="/wiki/August_8" title="August 8">8 August</a> <a href="/wiki/2006" title="2006">2006</a></span>.</li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZarate_C.2C_Singh_J.2C_Carlson_P.2C_Brutsche_N.2C_Ameli_R.2C_Luckenbaugh_D.2C_Charney_D.2C_Manji_H2006">Zarate C, Singh J, Carlson P, Brutsche N, Ameli R, Luckenbaugh D, Charney D, Manji H (2006). "A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression". <i>Arch Gen Psychiatry</i> <b>63</b> (8): 856–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchpsyc.63.8.856" class="external text" title="http://dx.doi.org/10.1001%2Farchpsyc.63.8.856" rel="nofollow">10.1001/archpsyc.63.8.856</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16894061" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16894061">PMID 16894061</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomized+trial+of+an+N-methyl-D-aspartate+antagonist+in+treatment-resistant+major+depression&amp;rft.jtitle=Arch+Gen+Psychiatry&amp;rft.aulast=Zarate+C%2C+Singh+J%2C+Carlson+P%2C+Brutsche+N%2C+Ameli+R%2C+Luckenbaugh+D%2C+Charney+D%2C+Manji+H&amp;rft.au=Zarate+C%2C+Singh+J%2C+Carlson+P%2C+Brutsche+N%2C+Ameli+R%2C+Luckenbaugh+D%2C+Charney+D%2C+Manji+H&amp;rft.date=2006&amp;rft.volume=63&amp;rft.issue=8&amp;rft.pages=856%E2%80%9364&amp;rft_id=info:doi/10.1001%2Farchpsyc.63.8.856&amp;rft_id=info:pmid/16894061&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBerman_R.2C_Cappiello_A.2C_Anand_A.2C_Oren_D.2C_Heninger_G.2C_Charney_D.2C_Krystal_J2000">Berman R, Cappiello A, Anand A, Oren D, Heninger G, Charney D, Krystal J (2000). "Antidepressant effects of ketamine in depressed patients". <i>Biol Psychiatry</i> <b>47</b> (4): 351–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2899%2900230-9" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2899%2900230-9" rel="nofollow">10.1016/S0006-3223(99)00230-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10686270" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10686270">PMID 10686270</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant+effects+of+ketamine+in+depressed+patients&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Berman+R%2C+Cappiello+A%2C+Anand+A%2C+Oren+D%2C+Heninger+G%2C+Charney+D%2C+Krystal+J&amp;rft.au=Berman+R%2C+Cappiello+A%2C+Anand+A%2C+Oren+D%2C+Heninger+G%2C+Charney+D%2C+Krystal+J&amp;rft.date=2000&amp;rft.volume=47&amp;rft.issue=4&amp;rft.pages=351%E2%80%934&amp;rft_id=info:doi/10.1016%2FS0006-3223%2899%2900230-9&amp;rft_id=info:pmid/10686270&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> Liebrenz M, Borgeat A, Leisinger R, Stohler R. Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly. 2007 <span class="mw-formatted-date" title="04-21"><a href="/wiki/April_21" title="April 21">April 21</a></span>;137(15-16):234-6</li>
<li id="cite_note-pmid17435569-28"><b><a href="#cite_ref-pmid17435569_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGoforth_HW.2C_Holsinger_T2007">Goforth HW, Holsinger T (2007). "Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy". <i>J ECT</i> <b>23</b> (1): 23–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.yct.0000263257.44539.23" class="external text" title="http://dx.doi.org/10.1097%2F01.yct.0000263257.44539.23" rel="nofollow">10.1097/01.yct.0000263257.44539.23</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17435569" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17435569">PMID 17435569</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Rapid+relief+of+severe+major+depressive+disorder+by+use+of+preoperative+ketamine+and+electroconvulsive+therapy&amp;rft.jtitle=J+ECT&amp;rft.aulast=Goforth+HW%2C+Holsinger+T&amp;rft.au=Goforth+HW%2C+Holsinger+T&amp;rft.date=2007&amp;rft.volume=23&amp;rft.issue=1&amp;rft.pages=23%E2%80%935&amp;rft_id=info:doi/10.1097%2F01.yct.0000263257.44539.23&amp;rft_id=info:pmid/17435569&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> "NIMH. "Faster-Acting Antidepressants Closer to Becoming a Reality." <span class="mw-formatted-date" title="2007-07-25"><span class="mw-formatted-date" title="07-25"><a href="/wiki/July_25" title="July 25">July 25</a></span>, <a href="/wiki/2007" title="2007">2007</a></span>, <a href="http://www.nimh.nih.gov/press/ketamine_2.cfm" class="external free" title="http://www.nimh.nih.gov/press/ketamine_2.cfm" rel="nofollow">http://www.nimh.nih.gov/press/ketamine_2.cfm</a></li>
<li id="cite_note-pmid12556568-30"><b><a href="#cite_ref-pmid12556568_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKrystal_AD.2C_Weiner_RD.2C_Dean_MD.2C_.27.27et_al.27.272003">Krystal AD, Weiner RD, Dean MD, <i>et al</i> (2003). "Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT". <i>J Neuropsychiatry Clin Neurosci</i> <b>15</b> (1): 27–34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12556568" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12556568">PMID 12556568</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Comparison+of+seizure+duration%2C+ictal+EEG%2C+and+cognitive+effects+of+ketamine+and+methohexital+anesthesia+with+ECT&amp;rft.jtitle=J+Neuropsychiatry+Clin+Neurosci&amp;rft.aulast=Krystal+AD%2C+Weiner+RD%2C+Dean+MD%2C+%27%27et+al%27%27&amp;rft.au=Krystal+AD%2C+Weiner+RD%2C+Dean+MD%2C+%27%27et+al%27%27&amp;rft.date=2003&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=27%E2%80%9334&amp;rft_id=info:pmid/12556568&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12088953-31"><b><a href="#cite_ref-pmid12088953_31-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKudoh_A.2C_Takahira_Y.2C_Katagai_H.2C_Takazawa_T2002">Kudoh A, Takahira Y, Katagai H, Takazawa T (2002). "Small-dose ketamine improves the postoperative state of depressed patients". <i>Anesth. Analg.</i> <b>95</b> (1): 114–8, table of contents. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00000539-200207000-00020" class="external text" title="http://dx.doi.org/10.1097%2F00000539-200207000-00020" rel="nofollow">10.1097/00000539-200207000-00020</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12088953" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12088953">PMID 12088953</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Small-dose+ketamine+improves+the+postoperative+state+of+depressed+patients&amp;rft.jtitle=Anesth.+Analg.&amp;rft.aulast=Kudoh+A%2C+Takahira+Y%2C+Katagai+H%2C+Takazawa+T&amp;rft.au=Kudoh+A%2C+Takahira+Y%2C+Katagai+H%2C+Takazawa+T&amp;rft.date=2002&amp;rft.volume=95&amp;rft.issue=1&amp;rft.pages=114%E2%80%938%2C+table+of+contents&amp;rft_id=info:doi/10.1097%2F00000539-200207000-00020&amp;rft_id=info:pmid/12088953&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17884272-32"><b><a href="#cite_ref-pmid17884272_32-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGarcia_LS.2C_Comim_CM.2C_Valvassori_SS.2C_.27.27et_al.27.272008">Garcia LS, Comim CM, Valvassori SS, <i>et al</i> (2008). "Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus". <i>Prog. Neuropsychopharmacol. Biol. Psychiatry</i> <b>32</b> (1): 140–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.pnpbp.2007.07.027" class="external text" title="http://dx.doi.org/10.1016%2Fj.pnpbp.2007.07.027" rel="nofollow">10.1016/j.pnpbp.2007.07.027</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17884272" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17884272">PMID 17884272</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acute+administration+of+ketamine+induces+antidepressant-like+effects+in+the+forced+swimming+test+and+increases+BDNF+levels+in+the+rat+hippocampus&amp;rft.jtitle=Prog.+Neuropsychopharmacol.+Biol.+Psychiatry&amp;rft.aulast=Garcia+LS%2C+Comim+CM%2C+Valvassori+SS%2C+%27%27et+al%27%27&amp;rft.au=Garcia+LS%2C+Comim+CM%2C+Valvassori+SS%2C+%27%27et+al%27%27&amp;rft.date=2008&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=140%E2%80%934&amp;rft_id=info:doi/10.1016%2Fj.pnpbp.2007.07.027&amp;rft_id=info:pmid/17884272&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <a href="http://www.eleusis.us/resource-center/references/acamethod.php" class="external text" title="http://www.eleusis.us/resource-center/references/acamethod.php" rel="nofollow">The Combination of Psychedelic and Aversive Approaches in Alcoholism Treatment - Eleusis</a></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> Krupitsky EM, Grinenko AY. Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. J Psychoactive Drugs. 1997 Apr-Jun;29(2):165-83. Review.</li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <a href="http://www.eleusis.us/resource-center/references/ketamine-psychotherapy-heroin.pdf" class="external free" title="http://www.eleusis.us/resource-center/references/ketamine-psychotherapy-heroin.pdf" rel="nofollow">http://www.eleusis.us/resource-center/references/ketamine-psychotherapy-heroin.pdf</a></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> 26. Krupitsky EM, Burakov AM, Dunaevsky IV, Romanova TN, Slavina TY, Grinenko AY. Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. J Psychoactive Drugs. 2007 Mar;39(1):13-9. PMID: 17523581 [PubMed - indexed for MEDLINE]</li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> Michael J. Winkelman and Thomas B., Roberts (editors) Westport, CT: Praeger/Greenwood</li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16850072&amp;query_hl=24&amp;itool=pubmed_docsum" class="external autonumber" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16850072&amp;query_hl=24&amp;itool=pubmed_docsum" rel="nofollow">[1]</a> Goldberg ME, Domsky R, Scaringe D, Hirsh R, Dotson J, Sharaf I, Torjman MC, Schwartzman RJ. "Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome".Pain Physician. 2005 Apr;8(2):175-9.</li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004 Sep;5(3):263-75.</li>
<li id="cite_note-cnn_rsd_coma-40">^ <a href="#cite_ref-cnn_rsd_coma_40-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cnn_rsd_coma_40-1" title=""><sup><i><b>b</b></i></sup></a> <a href="http://www.rsdfoundation.org/en/CNN_Transcript_RSD.htm" class="external autonumber" title="http://www.rsdfoundation.org/en/CNN_Transcript_RSD.htm" rel="nofollow">[2]</a> CNN report on ketamine therapy for CRPS/RSD <span class="mw-formatted-date" title="2006-09-01"><span class="mw-formatted-date" title="09-01"><a href="/wiki/September_1" title="September 1">September 1</a></span>, <a href="/wiki/2006" title="2006">2006</a></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> Kiefer RT, Rohr P, Ploppa A, Altemeyer KH, Schwartzman RJ. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract. 2007 Jun;7(2):147-50.</li>
<li id="cite_note-postopms-42"><b><a href="#cite_ref-postopms_42-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFLundberg2008">Lundberg, George D. (2008-10-09). <a href="http://www.medscape.com/viewarticle/581018" class="external text" title="http://www.medscape.com/viewarticle/581018" rel="nofollow">"Postoperative Ketamine Can Reduce Morphine Consumption and Nausea"</a>. Medscape<span class="printonly">. <a href="http://www.medscape.com/viewarticle/581018" class="external free" title="http://www.medscape.com/viewarticle/581018" rel="nofollow">http://www.medscape.com/viewarticle/581018</a></span><span class="reference-accessdate">. Retrieved on 2008-11-04</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Postoperative+Ketamine+Can+Reduce+Morphine+Consumption+and+Nausea&amp;rft.atitle=&amp;rft.aulast=Lundberg&amp;rft.aufirst=George+D.&amp;rft.au=Lundberg%2C+George+D.&amp;rft.date=2008-10-09&amp;rft.pub=Medscape&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F581018&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-PMID15055891-43"><b><a href="#cite_ref-PMID15055891_43-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTogal_T.2C_Demirbilek_S.2C_Koroglu_A.2C_Yapici_E.2C_Ersoy_O.2004">Togal T, Demirbilek S, Koroglu A, Yapici E, Ersoy O. (2004). "Effects of S(+) ketamine added to bupivacaine for spinal anaesthesia for prostate surgery in elderly patients". <i>Eur J Anaesthesiol</i> <b>21</b> (3): 193–197. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1017%2FS0265021504003059" class="external text" title="http://dx.doi.org/10.1017%2FS0265021504003059" rel="nofollow">10.1017/S0265021504003059</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1505589" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1505589">PMID 1505589</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+S%28%2B%29+ketamine+added+to+bupivacaine+for+spinal+anaesthesia+for+prostate+surgery+in+elderly+patients&amp;rft.jtitle=Eur+J+Anaesthesiol&amp;rft.aulast=Togal+T%2C+Demirbilek+S%2C+Koroglu+A%2C+Yapici+E%2C+Ersoy+O.&amp;rft.au=Togal+T%2C+Demirbilek+S%2C+Koroglu+A%2C+Yapici+E%2C+Ersoy+O.&amp;rft.date=2004&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=193%E2%80%93197&amp;rft_id=info:doi/10.1017%2FS0265021504003059&amp;rft_id=info:pmid/1505589&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <a href="http://ftdodge.naccvp.com/view.php?u=country&amp;p=msds&amp;prodnum=1003101.HTM" class="external text" title="http://ftdodge.naccvp.com/view.php?u=country&amp;p=msds&amp;prodnum=1003101.HTM" rel="nofollow">Fort Dodge (devision of Wyeth) Ketamine Lable</a>. Article retrieved on <span class="mw-formatted-date" title="2008-11-01"><a href="/wiki/Nov_1" title="Nov 1" class="mw-redirect">1 Nov</a> <a href="/wiki/2008" title="2008">2008</a></span></li>
<li id="cite_note-45"><b><a href="#cite_ref-45" title="">^</a></b> Kelland et al. (1993)Physiol Behav. 54(3):547-54.PMID: 8415949</li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> Chen et al. (2009), J Neurosci. 29(3):600-609;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15958747" class="external text" title="http://www.ncbi.nlm.nih.gov/pubmed/15958747" rel="nofollow">PMID 15958747</a></li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> Carr et al. (2007) J Physiol. 584(2): 437-450; <a href="http://www.ncbi.nlm.nih.gov/pubmed/17702809" class="external text" title="http://www.ncbi.nlm.nih.gov/pubmed/17702809" rel="nofollow">PMID 17702809</a></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> Chen et al. (2009), J Neurosci. 29(3):600-609;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15958747" class="external text" title="http://www.ncbi.nlm.nih.gov/pubmed/15958747" rel="nofollow">PMID 15958747</a></li>
<li id="cite_note-pmid11606328-49"><b><a href="#cite_ref-pmid11606328_49-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCoates_KM.2C_Flood_P2001">Coates KM, Flood P (October 2001). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1573008" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1573008" rel="nofollow">Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes</a>". <i>Br. J. Pharmacol.</i> <b>134</b> (4): 871–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.bjp.0704315" class="external text" title="http://dx.doi.org/10.1038%2Fsj.bjp.0704315" rel="nofollow">10.1038/sj.bjp.0704315</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11606328" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11606328">PMID 11606328</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine+and+its+preservative%2C+benzethonium+chloride%2C+both+inhibit+human+recombinant+alpha7+and+alpha4beta2+neuronal+nicotinic+acetylcholine+receptors+in+Xenopus+oocytes&amp;rft.jtitle=Br.+J.+Pharmacol.&amp;rft.aulast=Coates+KM%2C+Flood+P&amp;rft.au=Coates+KM%2C+Flood+P&amp;rft.date=October+2001&amp;rft.volume=134&amp;rft.issue=4&amp;rft.pages=871%E2%80%939&amp;rft_id=info:doi/10.1038%2Fsj.bjp.0704315&amp;rft_id=info:pmid/11606328&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> Togal T, Demirbilek S, Koroglu A, Yapici E, Ersoy O. Effects of S(+) ketamine added to bupivacaine for spinal anaesthesia for prostate surgery in elderly patients. European Journal of Anaesthesiology (2004), 21: 193-197.</li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBenoit_E1995">Benoit E (1995). "Effects of intravenous anaesthetics on nerve axons". <i>Eur J Anaesthesiol</i> <b>12</b> (1): 59–70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7705328" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7705328">PMID 7705328</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+intravenous+anaesthetics+on+nerve+axons&amp;rft.jtitle=Eur+J+Anaesthesiol&amp;rft.aulast=Benoit+E&amp;rft.au=Benoit+E&amp;rft.date=1995&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=59%E2%80%9370&amp;rft_id=info:pmid/7705328&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWagner_L.2C_Gingrich_K.2C_Kulli_J.2C_Yang_J2001">Wagner L, Gingrich K, Kulli J, Yang J (2001). "Ketamine blockade of voltage-gated sodium channels: evidence for a shared receptor site with local anesthetics". <i>Anesthesiology</i> <b>95</b> (6): 1406–13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11748399" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11748399">PMID 11748399</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ketamine+blockade+of+voltage-gated+sodium+channels%3A+evidence+for+a+shared+receptor+site+with+local+anesthetics&amp;rft.jtitle=Anesthesiology&amp;rft.aulast=Wagner+L%2C+Gingrich+K%2C+Kulli+J%2C+Yang+J&amp;rft.au=Wagner+L%2C+Gingrich+K%2C+Kulli+J%2C+Yang+J&amp;rft.date=2001&amp;rft.volume=95&amp;rft.issue=6&amp;rft.pages=1406%E2%80%9313&amp;rft_id=info:pmid/11748399&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> Shibuta S, Varathan S, Mashimo T. Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide. Br J Anaesth. 2006 Oct;97(4):517-24. Epub <span class="mw-formatted-date" title="08-23"><a href="/wiki/August_23" title="August 23">August 23</a></span> 2006.</li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <a href="http://sportsillustrated.cnn.com/2007/more/07/18/steroids0424/1.html" class="external text" title="http://sportsillustrated.cnn.com/2007/more/07/18/steroids0424/1.html" rel="nofollow">SI.com - More Sports - The Mexican Connection (cont.) - Wednesday </a><a href="/wiki/July_18" title="July 18">July 18</a>, 2007 3:35PM</li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> <a href="http://whqlibdoc.who.int/trs/WHO_TRS_915.pdf" class="external text" title="http://whqlibdoc.who.int/trs/WHO_TRS_915.pdf" rel="nofollow">Untitled-59</a></li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <a href="http://abcnews.go.com/Health/Depression/story?id=2282814&amp;page=1" class="external text" title="http://abcnews.go.com/Health/Depression/story?id=2282814&amp;page=1" rel="nofollow">ABC News: Ketamine, a Tranquilizer and Popular Club Drug, May Work for Depression</a></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> Saunders, N., &amp; Heron, L., (1993) <i>E for Ecstasy</i> (Paperback), N. Saunders, London. (<a href="/wiki/Special:BookSources/0950162884" class="internal">ISBN 0950162884</a>)</li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> See: <a href="http://ecstasy.org/testing/pillstilJuly.html" class="external autonumber" title="http://ecstasy.org/testing/pillstilJuly.html" rel="nofollow">[3]</a> for details online.</li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <a href="http://www.erowid.org/chemicals/ketamine/ketamine_dose.shtml" class="external text" title="http://www.erowid.org/chemicals/ketamine/ketamine_dose.shtml" rel="nofollow">Erowid Ketamine Vault: Dosage</a></li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> AJ Giannini, RH Loiselle, MC Giannini, WA Price. Phencyclidine and the dissociatives. Medical Psychiatry. 3(3):197-204, 1987.</li>
<li id="cite_note-61"><b><a href="#cite_ref-61" title="">^</a></b> AJ Giannini,RH loisellle, MC Giannini, WA Price, 1987, op. cit.</li>
<li id="cite_note-62"><b><a href="#cite_ref-62" title="">^</a></b> AJ Giannini,N Underwood, M Condon. Acute ketamine intoxication treated by haloperidol.American Journal of Therapeutics. 7:389-743,2000, <a href="http://www.ncbi.nlm.nih.gov/pubmed/11304647" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11304647">PMID 11304647</a>.</li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> AJ Giannini. Drugs of Abuse:Second Edition. Los Angeles,Practice Management Information Company,1997. <a href="/wiki/Special:BookSources/1570660530" class="internal">ISBN 1-57066-053-0</a>.</li>
<li id="cite_note-64"><b><a href="#cite_ref-64" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOlney_J.2C_Labruyere_J.2C_Price_M1989">Olney J, Labruyere J, Price M (1989). "Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs". <i>Science</i> <b>244</b> (4910): 13ggyryteyt60–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1126%2Fscience.2660263" class="external text" title="http://dx.doi.org/10.1126%2Fscience.2660263" rel="nofollow">10.1126/science.2660263</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2660263" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2660263">PMID 2660263</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pathological+changes+induced+in+cerebrocortical+neurons+by+phencyclidine+and+related+drugs&amp;rft.jtitle=Science&amp;rft.aulast=Olney+J%2C+Labruyere+J%2C+Price+M&amp;rft.au=Olney+J%2C+Labruyere+J%2C+Price+M&amp;rft.date=1989&amp;rft.volume=244&amp;rft.issue=4910&amp;rft.pages=13ggyryteyt60%E2%80%932&amp;rft_id=info:doi/10.1126%2Fscience.2660263&amp;rft_id=info:pmid/2660263&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-dxm_health-65">^ <a href="#cite_ref-dxm_health_65-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-dxm_health_65-1" title=""><sup><i><b>b</b></i></sup></a> <a href="http://www.erowid.org/chemicals/dxm/dxm_health2.shtml" class="external text" title="http://www.erowid.org/chemicals/dxm/dxm_health2.shtml" rel="nofollow">Erowid DXM Vaults: Health: The Bad News Isn't In: A Look at Dissociative-Induced Brain Damage, by Anderson C</a></li>
<li id="cite_note-Tryba_et_al-66">^ <a href="#cite_ref-Tryba_et_al_66-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tryba_et_al_66-1" title=""><sup><i><b>b</b></i></sup></a> Tryba M, Gehling M. Clonidine--a potent analgesic adjuvant. Curr Opin Anaesthesiol. 2002 Oct;15(5):511-7</li>
<li id="cite_note-67"><b><a href="#cite_ref-67" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHargreaves_R.2C_Hill_R.2C_Iversen_L">Hargreaves R, Hill R, Iversen L. "Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology". <i>Acta Neurochir Suppl (Wien)</i> <b>60</b>: 15–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7976530" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7976530">PMID 7976530</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neuroprotective+NMDA+antagonists%3A+the+controversy+over+their+potential+for+adverse+effects+on+cortical+neuronal+morphology&amp;rft.jtitle=Acta+Neurochir+Suppl+%28Wien%29&amp;rft.aulast=Hargreaves+R%2C+Hill+R%2C+Iversen+L&amp;rft.au=Hargreaves+R%2C+Hill+R%2C+Iversen+L&amp;rft.volume=60&amp;rft.pages=15%E2%80%939&amp;rft_id=info:pmid/7976530&amp;rfr_id=info:sid/en.wikipedia.org:Ketamine"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-68"><b><a href="#cite_ref-68" title="">^</a></b> AJ Giannini, N Underwood, M Condon op. cit.</li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> <a href="http://www.bmj.com/cgi/content/extract/336/7651/973" class="external text" title="http://www.bmj.com/cgi/content/extract/336/7651/973" rel="nofollow">BMJ - Urinary tract disease associated with chronic ketamine use</a></li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> Shahani R, Streutker C, Dickson B, Stewart RJ. <a href="http://www.goldjournal.net/article/PIIS009042950700101X/abstract" class="external text" title="http://www.goldjournal.net/article/PIIS009042950700101X/abstract" rel="nofollow">Ketamine-associated ulcerative cystitis: a new clinical entity</a>. Urology. 2007 May;69(5):810-2.</li>
<li id="cite_note-71"><b><a href="#cite_ref-71" title="">^</a></b> <a href="http://www.barethemusical.com/about/" class="external free" title="http://www.barethemusical.com/about/" rel="nofollow">http://www.barethemusical.com/about/</a></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketamine&amp;action=edit&amp;section=17" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.emcdda.europa.eu/index.cfm?fuseaction=public.Content&amp;nNodeID=431" class="external text" title="http://www.emcdda.europa.eu/index.cfm?fuseaction=public.Content&amp;nNodeID=431" rel="nofollow">EMCDDA Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs</a></li>
<li><a href="http://www.emedicine.com/emerg/topic802.htm" class="external text" title="http://www.emedicine.com/emerg/topic802.htm" rel="nofollow">eMedicine: Ketamine Emergency Applications</a></li>
<li><a href="http://www.erowid.org/culture/characters/lilly_john/lilly_john.shtml" class="external text" title="http://www.erowid.org/culture/characters/lilly_john/lilly_john.shtml" rel="nofollow">Erowid.org's John C. Lilly Vault</a></li>
<li><a href="http://www.maps.org/catalog/product_info.php?cPath=22_27&amp;products_id=35" class="external text" title="http://www.maps.org/catalog/product_info.php?cPath=22_27&amp;products_id=35" rel="nofollow">Ketamine Dreams and Realities</a> by Karl Jansen MD: thorough book, excellent on society's dysfunctional fear of psychedelics</li>
<li><a href="http://eleusis.us/resource-center/references.php" class="external text" title="http://eleusis.us/resource-center/references.php" rel="nofollow">Eleusis</a> References on the uses of ketamine as an entheogen for treating alcoholism, the use of ketamine in psychiatry, and for treating drug addiction</li>
<li><a href="http://www.mapinc.org/tlcnews/v05/n1371/a03.htm?158" class="external text" title="http://www.mapinc.org/tlcnews/v05/n1371/a03.htm?158" rel="nofollow">Radical Relief</a> Use of ketamine as an agent to "reboot" the brain of a patient in chemically induced coma to greatly diminish chronic pain.</li>
<li><a href="http://www.nature.com/news/2006/060807/full/060807-1.html" class="external text" title="http://www.nature.com/news/2006/060807/full/060807-1.html" rel="nofollow">Club drug finds use as antidepressant</a> - Psychedelic ketamine hits the blues surprisingly fast; Nature.com</li>
<li><a href="http://www.lifecds.com" class="external text" title="http://www.lifecds.com" rel="nofollow">Rehab clinic in Puerto Penasco Mexico that uses ketamine to detox it's patients from opiates</a></li>
<li><a href="http://media.libsyn.com/media/sciencefriday/scifri-2007072724.mp3" class="external text" title="http://media.libsyn.com/media/sciencefriday/scifri-2007072724.mp3" rel="nofollow">Ketamine and Depression</a> <a href="/wiki/Science_Friday" title="Science Friday">Science Friday</a> <a href="/wiki/Mp3" title="Mp3" class="mw-redirect">mp3</a> <a href="/wiki/Podcast" title="Podcast">podcast</a> about new research in <a href="/wiki/Biological_psychiatry" title="Biological psychiatry">biological psychiatry</a> and ketamine</li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Dissociative_psychedelics" title="Template:Dissociative psychedelics"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Dissociative_psychedelics" title="Template talk:Dissociative psychedelics"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Dissociative_psychedelics&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Dissociative_psychedelics&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Dissociative_drug" title="Dissociative drug">Dissociative</a> <a href="/wiki/Psychedelics,_dissociatives_and_deliriants" title="Psychedelics, dissociatives and deliriants">hallucinogens</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/Kappa_opioid_receptor" title="Kappa opioid receptor" class="mw-redirect">Kappa agonists</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cyclazocine" title="Cyclazocine">Cyclazocine</a>&#160;• <a href="/wiki/Enadoline" title="Enadoline">Enadoline</a>&#160;• <a href="/wiki/HZ-2" title="HZ-2">HZ-2</a>&#160;• <a href="/wiki/Salvinorin_A" title="Salvinorin A">Salvinorin A</a>&#160;• <a href="/wiki/Pentazocine" title="Pentazocine">Pentazocine</a>&#160;• <a href="/wiki/Spiradoline" title="Spiradoline">Spiradoline</a>&#160;• <a href="/wiki/Tifluadom" title="Tifluadom">Tifluadom</a>&#160;• <a href="/wiki/U-50488" title="U-50488">U-50488</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;"><a href="/wiki/NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonists</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/2-MDP" title="2-MDP">2-MDP</a>&#160;• <a href="/w/index.php?title=4-MeO-PCP&amp;action=edit&amp;redlink=1" class="new" title="4-MeO-PCP (page does not exist)">4-MeO-PCP</a>&#160;• <a href="/wiki/8a-Phenyldecahydroquinoline" title="8a-Phenyldecahydroquinoline">8a-Phenyldecahydroquinoline</a>&#160;• <a href="/wiki/Aptiganel" title="Aptiganel">Aptiganel</a>&#160;• <a href="/wiki/Dexoxadrol" title="Dexoxadrol">Dexoxadrol</a>&#160;• <a href="/wiki/Dextrorphan" title="Dextrorphan">Dextrorphan</a>&#160;• <a href="/wiki/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a>&#160;• <a href="/wiki/Dizocilpine" title="Dizocilpine">Dizocilpine</a>&#160;• <a href="/wiki/Esketamine" title="Esketamine">Esketamine</a>&#160;• <a href="/wiki/Etoxadrol" title="Etoxadrol">Etoxadrol</a>&#160;• <a href="/w/index.php?title=FPL-12495&amp;action=edit&amp;redlink=1" class="new" title="FPL-12495 (page does not exist)">FPL-12495</a>&#160;• <a href="/wiki/Gacyclidine" title="Gacyclidine">Gacyclidine</a>&#160;• <strong class="selflink">Ketamine</strong>&#160;• <a href="/wiki/Memantine" title="Memantine">Memantine</a>&#160;• <a href="/wiki/NEFA_(drug)" title="NEFA (drug)">NEFA</a>&#160;• <a href="/wiki/Eticyclidine" title="Eticyclidine">PCE</a>&#160;• <a href="/wiki/Phencyclidine" title="Phencyclidine">PCP</a>&#160;• <a href="/wiki/Remacemide" title="Remacemide">Remacemide</a>&#160;• <a href="/wiki/Rolicyclidine" title="Rolicyclidine">PCPy</a>&#160;• <a href="/wiki/Selfotel" title="Selfotel">Selfotel</a>&#160;• <a href="/wiki/Tenocyclidine" title="Tenocyclidine">TCP</a>&#160;• <a href="/wiki/Tiletamine" title="Tiletamine">Tiletamine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";;">Others</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Efavirenz" title="Efavirenz">Efavirenz</a>&#160;• <a href="/wiki/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a>&#160;• <a href="/wiki/Xenon" title="Xenon">Xenon</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Glutamate_receptor_ligands" title="Template:Glutamate receptor ligands"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Glutamate_receptor_ligands&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Glutamate receptor ligands (page does not exist)"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Glutamate_receptor_ligands&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Glutamate_receptor_ligands&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Glutamate_receptor" title="Glutamate receptor">Glutamate receptor</a> ligands</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Ionotropic" title="Ionotropic" class="mw-redirect">Ionotropic</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/NMDA_receptor" title="NMDA receptor">NMDA</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><b>Agonists</b>; <a href="/wiki/NMDA" title="NMDA">NMDA</a>&#160;• <a href="/wiki/Tetrazolylglycine" title="Tetrazolylglycine">Tetrazolylglycine</a><br />
<b><a href="/wiki/NMDA_receptor_antagonist" title="NMDA receptor antagonist">Antagonists</a></b>; <i>Competitive antagonists</i>; <a href="/wiki/AP-7_(drug)" title="AP-7 (drug)">AP7</a>&#160;• <a href="/wiki/AP5" title="AP5">AP5</a>&#160;• <a href="/wiki/CGP-37849" title="CGP-37849">CGP-37849</a>&#160;• <a href="/wiki/CPPene" title="CPPene">Midafotel (CPPene)</a>&#160;• <a href="/wiki/PEAQX" title="PEAQX">PEAQX</a>&#160;• <a href="/wiki/Perzinfotel" title="Perzinfotel">Perzinfotel</a>&#160;• <a href="/w/index.php?title=Cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic_acid&amp;action=edit&amp;redlink=1" class="new" title="Cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid (page does not exist)">PPDA</a>&#160;• <a href="/w/index.php?title=Sdz_220-581&amp;action=edit&amp;redlink=1" class="new" title="Sdz 220-581 (page does not exist)">Sdz 220-581</a>&#160;• <a href="/wiki/Selfotel" title="Selfotel">Selfotel</a>; <i>Noncompetitive antagonists</i>; <a href="/wiki/Aptiganel" title="Aptiganel">Aptiganel</a>&#160;• <a href="/wiki/Dizocilpine" title="Dizocilpine">Dizocilpine</a>&#160;• <a href="/w/index.php?title=FPL-12495&amp;action=edit&amp;redlink=1" class="new" title="FPL-12495 (page does not exist)">FPL-12495</a>&#160;• <a href="/w/index.php?title=FR-115,427&amp;action=edit&amp;redlink=1" class="new" title="FR-115,427 (page does not exist)">FR-115,427</a>&#160;• <a href="/wiki/Gacyclidine" title="Gacyclidine">Gacyclidine</a>&#160;• <a href="/wiki/Hodgkinsine" title="Hodgkinsine">Hodgkinsine</a>&#160;• <a href="/w/index.php?title=HU-211&amp;action=edit&amp;redlink=1" class="new" title="HU-211 (page does not exist)">HU-211</a>&#160;• <a href="/w/index.php?title=Indantadol&amp;action=edit&amp;redlink=1" class="new" title="Indantadol (page does not exist)">Indantadol</a>&#160;• <a href="/w/index.php?title=Psychotridine&amp;action=edit&amp;redlink=1" class="new" title="Psychotridine (page does not exist)">Psychotridine</a>&#160;• <a href="/wiki/Remacemide" title="Remacemide">Remacemide</a>; <i>Uncompetitive channel blockers</i>; <a href="/wiki/2-MDP" title="2-MDP">2-MDP</a>&#160;• <a href="/wiki/8a-Phenyldecahydroquinoline" title="8a-Phenyldecahydroquinoline">8a-Phenyldecahydroquinoline</a>&#160;• <a href="/wiki/Amantadine" title="Amantadine">Amantadine</a>&#160;• <a href="/wiki/Budipine" title="Budipine">Budipine</a>&#160;• <a href="/wiki/Delucemine" title="Delucemine">Delucemine</a>&#160;• <a href="/wiki/Dexoxadrol" title="Dexoxadrol">Dexoxadrol</a>&#160;• <a href="/wiki/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a>&#160;• <a href="/wiki/Dextrorphan" title="Dextrorphan">Dextrorphan</a>&#160;• <a href="/w/index.php?title=Endopsychosin&amp;action=edit&amp;redlink=1" class="new" title="Endopsychosin (page does not exist)">Endopsychosin</a>&#160;• <a href="/wiki/Etoxadrol" title="Etoxadrol">Etoxadrol</a>&#160;• <a href="/wiki/Eticyclidine" title="Eticyclidine">Eticyclidine</a>&#160;• <a href="/wiki/Ibogaine" title="Ibogaine">Ibogaine</a>&#160;• <strong class="selflink">Ketamine</strong>&#160;• <a href="/wiki/Memantine" title="Memantine">Memantine</a>&#160;• <a href="/wiki/NEFA_(drug)" title="NEFA (drug)">NEFA</a>&#160;• <a href="/wiki/Neramexane" title="Neramexane">Neramexane</a>&#160;• <a href="/wiki/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a>&#160;• <a href="/wiki/Phencyclidine" title="Phencyclidine">Phencyclidine</a>&#160;• <a href="/wiki/Rhynchophylline" title="Rhynchophylline">Rhynchophylline</a>&#160;• <a href="/wiki/Riluzole" title="Riluzole">Riluzole</a>&#160;• <a href="/wiki/Rolicyclidine" title="Rolicyclidine">Rolicyclidine</a>&#160;• <a href="/wiki/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a>&#160;• <a href="/wiki/Tiletamine" title="Tiletamine">Tiletamine</a>&#160;• <a href="/wiki/Xenon" title="Xenon">Xenon</a>; <i>Glycine site antagonists</i>; <a href="/w/index.php?title=1-Aminocyclopropanecarboxylic_acid&amp;action=edit&amp;redlink=1" class="new" title="1-Aminocyclopropanecarboxylic acid (page does not exist)">1-Aminocyclopropanecarboxylic acid</a>&#160;• <a href="/w/index.php?title=ACEA-1021&amp;action=edit&amp;redlink=1" class="new" title="ACEA-1021 (page does not exist)">ACEA-1021</a>&#160;• <a href="/w/index.php?title=7-Chlorokynurenate&amp;action=edit&amp;redlink=1" class="new" title="7-Chlorokynurenate (page does not exist)">7-Chlorokynurenate</a>&#160;• <a href="/w/index.php?title=CGP-39653&amp;action=edit&amp;redlink=1" class="new" title="CGP-39653 (page does not exist)">CGP-39653</a>&#160;• <a href="/wiki/DCKA" title="DCKA">DCKA</a>&#160;• <a href="/w/index.php?title=Gavestinel&amp;action=edit&amp;redlink=1" class="new" title="Gavestinel (page does not exist)">Gavestinel</a>&#160;• <a href="/w/index.php?title=GV-150,526&amp;action=edit&amp;redlink=1" class="new" title="GV-150,526 (page does not exist)">GV-150,526</a>&#160;• <a href="/wiki/Kynurenic_acid" title="Kynurenic acid">Kynurenic acid</a>&#160;• <a href="/w/index.php?title=L-689,560&amp;action=edit&amp;redlink=1" class="new" title="L-689,560 (page does not exist)">L-689,560</a>&#160;• <a href="/wiki/Lacosamide" title="Lacosamide">Lacosamide</a>&#160;• <a href="/w/index.php?title=ZD-9379&amp;action=edit&amp;redlink=1" class="new" title="ZD-9379 (page does not exist)">ZD-9379</a>; <i>Polyamine site antagonists</i>; <a href="/w/index.php?title=Besonprodil&amp;action=edit&amp;redlink=1" class="new" title="Besonprodil (page does not exist)">Besonprodil</a>&#160;• <a href="/w/index.php?title=CP-101,606&amp;action=edit&amp;redlink=1" class="new" title="CP-101,606 (page does not exist)">CP-101,606</a>&#160;• <a href="/wiki/Eliprodil" title="Eliprodil">Eliprodil</a>&#160;• <a href="/wiki/Ifenprodil" title="Ifenprodil">Ifenprodil</a>&#160;• <a href="/w/index.php?title=Ro25-6981&amp;action=edit&amp;redlink=1" class="new" title="Ro25-6981 (page does not exist)">Ro25-6981</a>&#160;• <a href="/w/index.php?title=Traxoprodil&amp;action=edit&amp;redlink=1" class="new" title="Traxoprodil (page does not exist)">Traxoprodil</a>; <i>Indirect antagonists</i>; <a href="/wiki/Lubeluzole" title="Lubeluzole">Lubeluzole</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/AMPA_receptor" title="AMPA receptor">AMPA</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><b><a href="/wiki/Ampakine" title="Ampakine">Agonists</a></b>; <a href="/wiki/5-Fluorowillardiine" title="5-Fluorowillardiine">5-Fluorowillardiine</a>&#160;• <a href="/wiki/AMPA" title="AMPA">AMPA</a>&#160;• <a href="/wiki/Domoic_acid" title="Domoic acid">Domoic acid</a>&#160;• <a href="/wiki/Quisqualic_acid" title="Quisqualic acid">Quisqualic acid</a>; <i>Positive allosteric modulators</i>; <a href="/wiki/Aniracetam" title="Aniracetam">Aniracetam</a>&#160;• <a href="/wiki/Cyclothiazide" title="Cyclothiazide">Cyclothiazide</a>&#160;• <a href="/wiki/CX-516" title="CX-516">CX-516</a>&#160;• <a href="/wiki/CX-546" title="CX-546" class="mw-redirect">CX-546</a>&#160;• <a href="/wiki/CX-614" title="CX-614" class="mw-redirect">CX-614</a>&#160;• <a href="/wiki/CX-691" title="CX-691" class="mw-redirect">CX-691</a>&#160;• <a href="/wiki/CX-717" title="CX-717" class="mw-redirect">CX-717</a>&#160;• <a href="/wiki/IDRA-21" title="IDRA-21">IDRA-21</a>&#160;• <a href="/w/index.php?title=LY-392,098&amp;action=edit&amp;redlink=1" class="new" title="LY-392,098 (page does not exist)">LY-392,098</a>&#160;• <a href="/wiki/LY-404,187" title="LY-404,187">LY-404,187</a>&#160;• <a href="/w/index.php?title=LY-451,395&amp;action=edit&amp;redlink=1" class="new" title="LY-451,395 (page does not exist)">LY-451,395</a>&#160;• <a href="/w/index.php?title=LY-451,646&amp;action=edit&amp;redlink=1" class="new" title="LY-451,646 (page does not exist)">LY-451,646</a>&#160;• <a href="/wiki/LY-503,430" title="LY-503,430">LY-503,430</a>&#160;• <a href="/wiki/Oxiracetam" title="Oxiracetam">Oxiracetam</a>&#160;• <a href="/wiki/PEPA_(drug)" title="PEPA (drug)">PEPA</a>&#160;• <a href="/wiki/Piracetam" title="Piracetam">Piracetam</a>&#160;• <a href="/wiki/Pramiracetam" title="Pramiracetam">Pramiracetam</a><br />
<b>Antagonists</b>; <a href="/w/index.php?title=ATPO&amp;action=edit&amp;redlink=1" class="new" title="ATPO (page does not exist)">ATPO</a>&#160;• <a href="/wiki/CNQX" title="CNQX">CNQX</a>&#160;• <a href="/wiki/DNQX" title="DNQX">DNQX</a>&#160;• <a href="/wiki/GYKI-52466" title="GYKI-52466">GYKI-52466</a>&#160;• <a href="/wiki/NBQX" title="NBQX">NBQX</a>&#160;• <a href="/wiki/Tezampanel" title="Tezampanel">Tezampanel (LY-293,558)</a>; <i>Negative allosteric modulators</i>; <a href="/w/index.php?title=GYKI-53,655&amp;action=edit&amp;redlink=1" class="new" title="GYKI-53,655 (page does not exist)">GYKI-53,655</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Kainate_receptor" title="Kainate receptor">Kainate</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><b>Agonists</b>; <a href="/wiki/5-Iodowillardiine" title="5-Iodowillardiine">5-Iodowillardiine</a>&#160;• <a href="/w/index.php?title=ATPA&amp;action=edit&amp;redlink=1" class="new" title="ATPA (page does not exist)">ATPA</a>&#160;• <a href="/wiki/Domoic_acid" title="Domoic acid">Domoic acid</a>&#160;• <a href="/wiki/Kainic_acid" title="Kainic acid">Kainic acid</a>&#160;• <a href="/w/index.php?title=LY-339,434&amp;action=edit&amp;redlink=1" class="new" title="LY-339,434 (page does not exist)">LY-339,434</a>&#160;• <a href="/w/index.php?title=SYM-2081&amp;action=edit&amp;redlink=1" class="new" title="SYM-2081 (page does not exist)">SYM-2081</a><br />
<b>Antagonists</b>; <a href="/wiki/CNQX" title="CNQX">CNQX</a>&#160;• <a href="/wiki/DNQX" title="DNQX">DNQX</a>&#160;• <a href="/w/index.php?title=LY-382,884&amp;action=edit&amp;redlink=1" class="new" title="LY-382,884 (page does not exist)">LY-382,884</a>&#160;• <a href="/wiki/NBQX" title="NBQX">NBQX</a>&#160;• <a href="/wiki/NS102" title="NS102">NS102</a>&#160;• <a href="/wiki/UBP-302" title="UBP-302">UBP-302</a>; <i>Negative allosteric modulators</i>; <a href="/w/index.php?title=NS-3763&amp;action=edit&amp;redlink=1" class="new" title="NS-3763 (page does not exist)">NS-3763</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Metabotropic_glutamate_receptor" title="Metabotropic glutamate receptor">Metabotropic</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Metabotropic_glutamate_receptor#Group_I" title="Metabotropic glutamate receptor">Group I</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><b>Agonists</b>; <i>Unselective</i>; <a href="/w/index.php?title=ACPD&amp;action=edit&amp;redlink=1" class="new" title="ACPD (page does not exist)">ACPD</a>&#160;• <a href="/wiki/Dihydroxyphenylglycine" title="Dihydroxyphenylglycine">Dihydroxyphenylglycine</a>&#160;• <a href="/wiki/Quisqualic_acid" title="Quisqualic acid">Quisqualic acid</a>; <i>mGlu1 selective</i>; <a href="/w/index.php?title=Ro01-6128&amp;action=edit&amp;redlink=1" class="new" title="Ro01-6128 (page does not exist)">Ro01-6128</a>; <i>mGlu5 selective</i>; <a href="/w/index.php?title=CDPPB&amp;action=edit&amp;redlink=1" class="new" title="CDPPB (page does not exist)">CDPPB</a>&#160;• <a href="/w/index.php?title=CHPG&amp;action=edit&amp;redlink=1" class="new" title="CHPG (page does not exist)">CHPG</a>&#160;• <a href="/w/index.php?title=1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine&amp;action=edit&amp;redlink=1" class="new" title="1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine (page does not exist)">DFB</a><br />
<b>Antagonists</b>; <i>Unselective</i>; <a href="/w/index.php?title=MCPG&amp;action=edit&amp;redlink=1" class="new" title="MCPG (page does not exist)">MCPG</a>; <i>mGlu1 selective</i>; <a href="/w/index.php?title=BAY_36-7620&amp;action=edit&amp;redlink=1" class="new" title="BAY 36-7620 (page does not exist)">BAY 36-7620</a>&#160;• <a href="/w/index.php?title=CPCCOEt&amp;action=edit&amp;redlink=1" class="new" title="CPCCOEt (page does not exist)">CPCCOEt</a>&#160;• <a href="/w/index.php?title=LY-367,385&amp;action=edit&amp;redlink=1" class="new" title="LY-367,385 (page does not exist)">LY-367,385</a>; <i>mGlu5 selective</i>; <a href="/wiki/Fenobam" title="Fenobam">Fenobam</a>&#160;• <a href="/wiki/LY-344,545" title="LY-344,545">LY-344,545</a>&#160;• <a href="/wiki/2-Methyl-6-(phenylethynyl)pyridine" title="2-Methyl-6-(phenylethynyl)pyridine">MPEP</a>&#160;• <a href="/wiki/MTEP" title="MTEP">MTEP</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Metabotropic_glutamate_receptor#Group_II_.26_Group_III" title="Metabotropic glutamate receptor">Group II</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><b>Agonists</b>; <i>Unselective</i>; <a href="/w/index.php?title=CBiPES&amp;action=edit&amp;redlink=1" class="new" title="CBiPES (page does not exist)">CBiPES</a>&#160;• <a href="/w/index.php?title=DCG-IV&amp;action=edit&amp;redlink=1" class="new" title="DCG-IV (page does not exist)">DCG-IV</a>&#160;• <a href="/wiki/Eglumegad" title="Eglumegad">Eglumegad (LY-354,740)</a>&#160;• <a href="/w/index.php?title=LY-379,268&amp;action=edit&amp;redlink=1" class="new" title="LY-379,268 (page does not exist)">LY-379,268</a>&#160;• <a href="/w/index.php?title=LY-404,039&amp;action=edit&amp;redlink=1" class="new" title="LY-404,039 (page does not exist)">LY-404,039</a>; <i>mGlu2 selective</i>; <a href="/wiki/Biphenylindanone_A" title="Biphenylindanone A">BINA</a>&#160;• <a href="/w/index.php?title=LY-487,379&amp;action=edit&amp;redlink=1" class="new" title="LY-487,379 (page does not exist)">LY-487,379</a><br />
<b>Antagonists</b>; <a href="/wiki/APICA_(drug)" title="APICA (drug)">APICA</a>&#160;• <a href="/wiki/EGLU" title="EGLU">EGLU</a>&#160;• <a href="/w/index.php?title=LY-307,452&amp;action=edit&amp;redlink=1" class="new" title="LY-307,452 (page does not exist)">LY-307,452</a>&#160;• <a href="/wiki/LY-341,495" title="LY-341,495">LY-341,495</a>&#160;• <a href="/w/index.php?title=MCCG&amp;action=edit&amp;redlink=1" class="new" title="MCCG (page does not exist)">MCCG</a>; <i>mGlu2 selective</i>; <a href="/w/index.php?title=PCCG-4&amp;action=edit&amp;redlink=1" class="new" title="PCCG-4 (page does not exist)">PCCG-4</a>; <i>mGlu3 selective</i>; <a href="/w/index.php?title=CECXG&amp;action=edit&amp;redlink=1" class="new" title="CECXG (page does not exist)">CECXG</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Metabotropic_glutamate_receptor#Group_II_.26_Group_III" title="Metabotropic glutamate receptor">Group III</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;width:auto;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><b>Agonists</b>; <i>Unselective</i>; <a href="/w/index.php?title=AP4&amp;action=edit&amp;redlink=1" class="new" title="AP4 (page does not exist)">AP4</a>; <i>mGlu4 selective</i>; <a href="/w/index.php?title=PHCCC&amp;action=edit&amp;redlink=1" class="new" title="PHCCC (page does not exist)">PHCCC</a>&#160;• <a href="/w/index.php?title=VU-001,171&amp;action=edit&amp;redlink=1" class="new" title="VU-001,171 (page does not exist)">VU-001,171</a>&#160;• <a href="/w/index.php?title=VU-0155,041&amp;action=edit&amp;redlink=1" class="new" title="VU-0155,041 (page does not exist)">VU-0155,041</a>; <i>mGlu7 selective</i>; <a href="/wiki/AMN082" title="AMN082">AMN082</a>; <i>mGlu8 selective</i>; <a href="/w/index.php?title=DCPG&amp;action=edit&amp;redlink=1" class="new" title="DCPG (page does not exist)">DCPG</a><br />
<b>Antagonists</b>; <i>Unselective</i>; <a href="/w/index.php?title=CPPG&amp;action=edit&amp;redlink=1" class="new" title="CPPG (page does not exist)">CPPG</a>&#160;• <a href="/w/index.php?title=MAP4_(drug)&amp;action=edit&amp;redlink=1" class="new" title="MAP4 (drug) (page does not exist)">MAP4</a>&#160;• <a href="/w/index.php?title=MSOP_(drug)&amp;action=edit&amp;redlink=1" class="new" title="MSOP (drug) (page does not exist)">MSOP</a>&#160;• <a href="/w/index.php?title=MPPG&amp;action=edit&amp;redlink=1" class="new" title="MPPG (page does not exist)">MPPG</a>&#160;• <a href="/w/index.php?title=MTPG&amp;action=edit&amp;redlink=1" class="new" title="MTPG (page does not exist)">MTPG</a>&#160;• <a href="/w/index.php?title=UBP-1112&amp;action=edit&amp;redlink=1" class="new" title="UBP-1112 (page does not exist)">UBP-1112</a>; <i>mGlu7 selective</i>; <a href="/w/index.php?title=MMPIP&amp;action=edit&amp;redlink=1" class="new" title="MMPIP (page does not exist)">MMPIP</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:General_anesthetics" title="Template:General anesthetics"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:General_anesthetics&amp;action=edit&amp;redlink=1" class="new" title="Template talk:General anesthetics (page does not exist)"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:General_anesthetics&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:General_anesthetics&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Anesthetic" title="Anesthetic" class="mw-redirect">Anesthetic</a>: <a href="/wiki/General_anaesthetic" title="General anaesthetic">General anesthetics</a> (<a href="/wiki/ATC_code_N01#N01A_Anesthetics.2C_general" title="ATC code N01">N01A</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Inhalational_anaesthetic" title="Inhalational anaesthetic">Inhalation</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ether" title="Ether">Ethers</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Diethyl_ether" title="Diethyl ether">Diethyl ether</a>&#160;• <a href="/wiki/Methoxypropane" title="Methoxypropane">Methoxypropane</a>&#160;• <a href="/wiki/Vinyl_ether" title="Vinyl ether">Vinyl ether</a>&#160;• <i><a href="/wiki/Halogenated_ether" title="Halogenated ether">halogenated ethers</a></i> (<a href="/wiki/Desflurane" title="Desflurane">Desflurane</a>&#160;• <a href="/wiki/Enflurane" title="Enflurane">Enflurane</a>&#160;• <a href="/wiki/Isoflurane" title="Isoflurane">Isoflurane</a>&#160;• <a href="/wiki/Methoxyflurane" title="Methoxyflurane">Methoxyflurane</a>&#160;• <a href="/wiki/Sevoflurane" title="Sevoflurane">Sevoflurane</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Haloalkane" title="Haloalkane">Haloalkanes</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Chloroform" title="Chloroform">Chloroform</a>&#160;• <a href="/wiki/Halothane" title="Halothane">Halothane</a> # &#160;• <a href="/wiki/Trichloroethylene" title="Trichloroethylene">Trichloroethylene</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Others</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cyclopropane" title="Cyclopropane">Cyclopropane</a>&#160;• <a href="/wiki/Ethylene" title="Ethylene">Ethylene</a>&#160;• <a href="/wiki/Nitrous_oxide" title="Nitrous oxide">Nitrous oxide</a> # &#160;• <a href="/wiki/Xenon" title="Xenon">Xenon</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/General_anaesthetic#Injection" title="General anaesthetic">Injection</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Barbiturate" title="Barbiturate">Barbiturates</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Hexobarbital" title="Hexobarbital">Hexobarbital</a>&#160;• <a href="/wiki/Methohexital" title="Methohexital">Methohexital</a>&#160;• <a href="/wiki/Narcobarbital" title="Narcobarbital">Narcobarbital</a>&#160;• <a href="/wiki/Sodium_thiopental" title="Sodium thiopental">Thiopental</a> #</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Opioid" title="Opioid">Opioids</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Alfentanil" title="Alfentanil">Alfentanil</a>&#160;• <a href="/wiki/Anileridine" title="Anileridine">Anileridine</a>&#160;• <a href="/wiki/Fentanyl" title="Fentanyl">Fentanyl</a>&#160;• <a href="/wiki/Phenoperidine" title="Phenoperidine">Phenoperidine</a>&#160;• <a href="/wiki/Remifentanil" title="Remifentanil">Remifentanil</a>&#160;• <a href="/wiki/Sufentanil" title="Sufentanil">Sufentanil</a>&#160;</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neuroactive_steroid" title="Neuroactive steroid">Neuroactive steroids</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Alfaxalone" title="Alfaxalone">Alfaxalone</a>&#160;• <a href="/wiki/Minaxolone" title="Minaxolone">Minaxolone</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Others</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Droperidol" title="Droperidol">Droperidol</a>&#160;• <a href="/wiki/Etomidate" title="Etomidate">Etomidate</a>&#160;• <a href="/wiki/Fospropofol" title="Fospropofol">Fospropofol</a>&#160;• <a href="/wiki/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">gamma-Hydroxybutyric acid</a>&#160;• <strong class="selflink">Ketamine</strong> # /<a href="/wiki/Esketamine" title="Esketamine">Esketamine</a>&#160;• <a href="/wiki/Midazolam" title="Midazolam">Midazolam</a>&#160;• <a href="/wiki/Propanidid" title="Propanidid">Propanidid</a>&#160;• <a href="/wiki/Propofol" title="Propofol">Propofol</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i># = <a href="/wiki/List_of_World_Health_Organization_Essential_Medicines" title="List of World Health Organization Essential Medicines">WHO-EM</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 18840/1000000
Post-expand include size: 231584/2048000 bytes
Template argument size: 104022/2048000 bytes
Expensive parser function count: 14/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:16948-0!1!0!default!!en!2 and timestamp 20090405063456 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Ketamine">http://en.wikipedia.org/wiki/Ketamine</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Anesthetics" title="Category:Anesthetics">Anesthetics</a></span> | <span dir='ltr'><a href="/wiki/Category:Dissociative_drugs" title="Category:Dissociative drugs">Dissociative drugs</a></span> | <span dir='ltr'><a href="/wiki/Category:NMDA_receptor_antagonists" title="Category:NMDA receptor antagonists">NMDA receptor antagonists</a></span> | <span dir='ltr'><a href="/wiki/Category:Sedatives" title="Category:Sedatives">Sedatives</a></span> | <span dir='ltr'><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></span> | <span dir='ltr'><a href="/wiki/Category:American_inventions" title="Category:American inventions">American inventions</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_December_2008" title="Category:Articles with unsourced statements since December 2008">Articles with unsourced statements since December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_November_2007" title="Category:Articles with unsourced statements since November 2007">Articles with unsourced statements since November 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_July_2007" title="Category:Articles with unsourced statements since July 2007">Articles with unsourced statements since July 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2007" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_additional_references_from_December_2008" title="Category:Articles needing additional references from December 2008">Articles needing additional references from December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2007" title="Category:Articles with unsourced statements since August 2007">Articles with unsourced statements since August 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Ketamine" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Ketamine" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Ketamine&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Ketamine&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Ketamine" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Ketamine" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Ketamine" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Ketamine&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Ketamine&amp;oldid=281164294" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Ketamine&amp;id=281164294">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Ketamina">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Ketamin">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Ketamin">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Ketamin">Deutsch</a></li>
				<li class="interwiki-et"><a href="http://et.wikipedia.org/wiki/Ketamiin">Eesti</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Ketamina">Español</a></li>
				<li class="interwiki-eu"><a href="http://eu.wikipedia.org/wiki/Ketamina">Euskara</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/K%C3%A9tamine">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Ketamina">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%A7%D7%98%D7%9E%D7%99%D7%9F">עברית</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Ketamine">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%82%B1%E3%82%BF%E3%83%9F%E3%83%B3">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Ketamin">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Ketamina">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Cloridrato_de_cetamina">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9A%D0%B5%D1%82%D0%B0%D0%BC%D0%B8%D0%BD">Русский</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Ketamine">Simple English</a></li>
				<li class="interwiki-sk"><a href="http://sk.wikipedia.org/wiki/Ketam%C3%ADn">Slovenčina</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Ketamiini">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Ketamin">Svenska</a></li>
				<li class="interwiki-th"><a href="http://th.wikipedia.org/wiki/%E0%B8%84%E0%B8%B5%E0%B8%95%E0%B8%B2%E0%B8%A1%E0%B8%B5%E0%B8%99">ไทย</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%9A%D0%B5%D1%82%D0%B0%D0%BC%D1%96%D0%BD">Українська</a></li>
				<li class="interwiki-ur"><a href="http://ur.wikipedia.org/wiki/Ketamine">اردو</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E6%B0%AF%E8%83%BA%E9%85%AE">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 1 April 2009, at 22:01.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv97 in 0.108 secs. --></body></html>
